CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | gold atom |
|
Accession: | CHEBI:29287
|
browse the term
|
Definition: | A copper group element atom that has formula Au. |
Synonyms: | related_synonym: | 79Au; Au; Formula=Au; Gold; InChI=1S/Au; InChIKey=PCHJSUWPFVWCPO-UHFFFAOYSA-N; SMILES=[Au]; aurum; or; oro |
| xref: | CAS:7440-57-5 |
| xref_mesh: | MESH:D006046 |
| xref: | WebElements:Au |
|
|
|
G |
AASS |
aminoadipate-semialdehyde synthase |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of AASS mRNA Gold analog results in decreased expression of AASS mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression |
EXP |
Gold analog results in increased expression of ABCB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCB4 mRNA Gold analog results in decreased expression of ABCB4 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCC1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
increases expression |
EXP |
Gold analog results in increased expression of ABCC2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABL1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675
|
|
G |
ACAA1 |
acetyl-CoA acyltransferase 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of ACAA1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242
|
|
G |
ACACA |
acetyl-CoA carboxylase alpha |
decreases expression |
EXP |
Gold analog results in decreased expression of ACACA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
|
|
G |
ACAD11 |
acyl-CoA dehydrogenase family member 11 |
decreases expression |
EXP |
Gold analog results in decreased expression of ACAD11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:132,558,141...132,659,809
Ensembl chr 3:132,558,138...132,660,082
|
|
G |
ACADM |
acyl-CoA dehydrogenase medium chain |
decreases expression |
EXP |
Gold analog results in decreased expression of ACADM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575
|
|
G |
ACADS |
acyl-CoA dehydrogenase short chain |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADS mRNA |
CTD |
PMID:28433809 |
|
NCBI chr12:120,725,826...120,740,008
Ensembl chr12:120,725,774...120,740,008
|
|
G |
ACADVL |
acyl-CoA dehydrogenase very long chain |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA |
CTD |
PMID:28433809 |
|
NCBI chr17:7,217,125...7,225,266
Ensembl chr17:7,217,125...7,225,266
|
|
G |
ACO1 |
aconitase 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:32,384,643...32,454,769
Ensembl chr 9:32,384,603...32,454,769
|
|
G |
ACO2 |
aconitase 2 |
decreases expression multiple interactions |
ISO EXP |
Gold analog results in decreased expression of ACO2 protein [Polyethyleneimine binds to Gold] which results in increased expression of ACO2 mRNA |
CTD |
PMID:24780912 PMID:28433809 |
|
NCBI chr22:41,469,117...41,528,974
Ensembl chr22:41,447,830...41,529,273
|
|
G |
ACOX1 |
acyl-CoA oxidase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ACOX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177
|
|
G |
ACOX2 |
acyl-CoA oxidase 2 |
decreases expression |
EXP |
Gold analog results in decreased expression of ACOX2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283
|
|
G |
ACP1 |
acid phosphatase 1 |
decreases expression |
EXP |
Gold results in decreased expression of ACP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:264,947...278,283
Ensembl chr 2:264,140...278,283
|
|
G |
ACVR1C |
activin A receptor type 1C |
decreases expression |
EXP |
Gold results in decreased expression of ACVR1C mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:157,526,767...157,628,864
Ensembl chr 2:157,526,767...157,628,864
|
|
G |
ADAM28 |
ADAM metallopeptidase domain 28 |
increases expression |
EXP |
Gold results in increased expression of ADAM28 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 8:24,294,069...24,359,014
Ensembl chr 8:24,294,069...24,359,014
|
|
G |
ADH5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
decreases expression |
EXP |
Gold results in decreased expression of ADH5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:99,070,978...99,088,788
Ensembl chr 4:99,070,978...99,088,801
|
|
G |
ADIPOR2 |
adiponectin receptor 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674
|
|
G |
ADRA1B |
adrenoceptor alpha 1B |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRA1B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:159,865,086...159,989,205
Ensembl chr 5:159,865,080...159,973,012
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRB2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
AHSG |
alpha 2-HS glycoprotein |
decreases expression |
EXP |
Gold analog results in decreased expression of AHSG mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
increases expression |
EXP |
Gold results in increased expression of AIFM1 protein |
CTD |
PMID:25462594 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
AIMP1 |
aminoacyl tRNA synthetase complex interacting multifunctional protein 1 |
decreases expression |
EXP |
Gold results in decreased expression of AIMP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:106,315,544...106,349,456
Ensembl chr 4:106,315,544...106,349,456
|
|
G |
AK3 |
adenylate kinase 3 |
decreases expression |
EXP |
Gold results in decreased expression of AK3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:4,709,556...4,742,043
Ensembl chr 9:4,709,556...4,742,043
|
|
G |
AKAP13 |
A-kinase anchoring protein 13 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of AKAP13 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr15:85,380,603...85,749,358
Ensembl chr15:85,380,571...85,749,358
|
|
G |
AKR1B10 |
aldo-keto reductase family 1 member B10 |
increases expression |
EXP |
Gold results in increased expression of AKR1B10 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
|
|
G |
AKR1C2 |
aldo-keto reductase family 1 member C2 |
increases expression |
EXP |
Gold results in increased expression of AKR1C2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
|
|
G |
AKR1C3 |
aldo-keto reductase family 1 member C3 |
increases expression |
EXP |
Gold results in increased expression of AKR1C3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:27470402 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
ALB |
albumin |
multiple interactions increases expression |
EXP |
ALB protein results in increased uptake of [Polyethylene Glycols binds to Gold]; ALB protein results in increased uptake of [Polyethyleneimine binds to Gold]; ALB protein results in increased uptake of [Thioctic Acid binds to Gold] Gold analog results in increased expression of ALB mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ANXA5 |
annexin A5 |
increases expression |
ISO |
Gold analog results in increased expression of ANXA5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
|
|
G |
APAF1 |
apoptotic peptidase activating factor 1 |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of APAF1 mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of APAF1 protein Gold analog results in decreased expression of APAF1 mRNA |
CTD |
PMID:27470402 PMID:28433809 PMID:36057382 |
|
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
|
|
G |
APEX1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of APEX1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
|
|
G |
APOA4 |
apolipoprotein A4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of APOA4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
|
|
G |
APRT |
adenine phosphoribosyltransferase |
decreases expression |
ISO |
Gold analog results in decreased expression of APRT protein |
CTD |
PMID:24780912 |
|
NCBI chr16:88,809,339...88,811,928
Ensembl chr16:88,809,339...88,811,937
|
|
G |
AQP4 |
aquaporin 4 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of AQP4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
|
|
G |
ARL1 |
ARF like GTPase 1 |
decreases expression |
EXP |
Gold results in decreased expression of ARL1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:101,393,116...101,407,820
Ensembl chr12:101,393,116...101,407,772
|
|
G |
ARL5B |
ARF like GTPase 5B |
decreases expression |
EXP |
Gold results in decreased expression of ARL5B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:18,659,431...18,681,639
Ensembl chr10:18,659,431...18,681,639
|
|
G |
ARSG |
arylsulfatase G |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ARSG mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:68,259,170...68,452,019
Ensembl chr17:68,259,182...68,422,731
|
|
G |
ASAH1 |
N-acylsphingosine amidohydrolase 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of ASAH1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
|
|
G |
ATF1 |
activating transcription factor 1 |
decreases expression |
EXP |
Gold results in decreased expression of ATF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:50,763,459...50,821,162
Ensembl chr12:50,763,710...50,821,162
|
|
G |
ATF4 |
activating transcription factor 4 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ATF4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,686
|
|
G |
ATF6 |
activating transcription factor 6 |
increases cleavage |
EXP |
Gold analog results in increased cleavage of ATF6 protein |
CTD |
PMID:26551149 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
ATIC |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
decreases expression |
ISO |
Gold analog results in decreased expression of ATIC protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:215,312,059...215,368,592
Ensembl chr 2:215,311,956...215,349,773
|
|
G |
ATL2 |
atlastin GTPase 2 |
decreases expression |
EXP |
Gold results in decreased expression of ATL2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:38,293,954...38,378,584
Ensembl chr 2:38,293,954...38,377,285
|
|
G |
ATM |
ATM serine/threonine kinase |
decreases expression |
EXP |
Gold analog results in decreased expression of ATM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
|
|
G |
ATP2B1 |
ATPase plasma membrane Ca2+ transporting 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,366
|
|
G |
ATP5F1B |
ATP synthase F1 subunit beta |
multiple interactions |
ISO |
Gold analog results in increased expression of and results in decreased phosphorylation of ATP5F1B protein |
CTD |
PMID:24780912 |
|
NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984
|
|
G |
ATP6V1G2 |
ATPase H+ transporting V1 subunit G2 |
decreases expression |
EXP |
Gold analog results in decreased expression of ATP6V1G2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:31,544,444...31,546,742
Ensembl chr 6:31,544,444...31,548,427
|
|
G |
ATR |
ATR serine/threonine kinase |
decreases expression |
EXP |
Gold analog results in decreased expression of ATR mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
|
|
G |
BACE1 |
beta-secretase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BACE1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
|
|
G |
BAD |
BCL2 associated agonist of cell death |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in increased expression of BAD protein |
CTD |
PMID:27470402 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAIAP2 |
BAR/IMD domain containing adaptor protein 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of BAIAP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:81,035,151...81,117,434
Ensembl chr17:81,035,122...81,117,434
|
|
G |
BAK1 |
BCL2 antagonist/killer 1 |
increases expression |
EXP |
Gold results in increased expression of BAK1 mRNA |
CTD |
PMID:22178767 |
|
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein; [Gold analog co-treated with Platinum] results in increased expression of BAX mRNA; [Polyethyleneimine binds to Gold] which results in decreased expression of BAX mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of BAX protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of BAX protein Gold results in increased expression of BAX mRNA |
CTD |
PMID:21621595 PMID:22178767 PMID:25846798 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCAS2 |
BCAS2 pre-mRNA processing factor |
decreases expression |
EXP |
Gold results in decreased expression of BCAS2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:114,567,557...114,581,615
Ensembl chr 1:114,567,557...114,581,629
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP ISO |
[Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA; [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein |
CTD |
PMID:25846798 PMID:27470402 PMID:27836789 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BCL2L11 |
BCL2 like 11 |
decreases expression |
EXP |
Gold analog results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
|
|
G |
BIRC2 |
baculoviral IAP repeat containing 2 |
decreases expression |
EXP |
Gold results in decreased expression of BIRC2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
|
|
G |
BIRC3 |
baculoviral IAP repeat containing 3 |
decreases expression |
EXP |
Gold analog results in decreased expression of BIRC3 mRNA; Gold results in decreased expression of BIRC3 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
|
|
G |
BMAL1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BMAL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
|
|
G |
BMI1 |
BMI1 proto-oncogene, polycomb ring finger |
decreases expression |
EXP |
Gold results in decreased expression of BMI1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:22,321,099...22,331,706
Ensembl chr10:22,321,099...22,331,484
|
|
G |
BRCA1 |
BRCA1 DNA repair associated |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA1 mRNA Gold analog results in decreased expression of BRCA1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
|
|
G |
BRCA2 |
BRCA2 DNA repair associated |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA2 mRNA Gold analog results in decreased expression of BRCA2 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr13:32,315,077...32,400,268
Ensembl chr13:32,315,086...32,400,268
|
|
G |
C11orf54 |
chromosome 11 open reading frame 54 |
decreases expression |
EXP |
Gold results in decreased expression of C11ORF54 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:93,741,672...93,764,749
Ensembl chr11:93,741,591...93,764,749
|
|
G |
C1D |
C1D nuclear receptor corepressor |
decreases expression |
EXP |
Gold results in decreased expression of C1D mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:68,041,130...68,063,004
Ensembl chr 2:68,041,130...68,110,948
|
|
G |
C3 |
complement C3 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of C3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
C9 |
complement C9 |
decreases expression |
EXP |
Gold analog results in decreased expression of C9 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:39,284,140...39,364,495
Ensembl chr 5:39,284,140...39,371,324
|
|
G |
CA13 |
carbonic anhydrase 13 |
decreases expression |
EXP |
Gold results in decreased expression of CA13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:85,245,458...85,284,073
Ensembl chr 8:85,220,587...85,284,073
|
|
G |
CAPZA2 |
capping actin protein of muscle Z-line subunit alpha 2 |
decreases expression |
EXP |
Gold results in decreased expression of CAPZA2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:116,862,587...116,922,049
Ensembl chr 7:116,811,070...116,922,049
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of CASP1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity increases cleavage increases expression |
EXP ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP3 mRNA; [Polyethyleneimine binds to Gold] which results in increased expression of CASP3 mRNA; [Quercetin analog co-treated with Gold analog] results in increased cleavage of CASP3 protein; [Quercetin analog co-treated with Gold analog] results in increased expression of and results in increased activity of CASP3 protein; Dexamethasone promotes the reaction [Gold results in increased activity of CASP3 protein]; Etoposide promotes the reaction [Gold results in increased activity of CASP3 protein] [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP3 protein Gold analog results in increased cleavage of CASP3 protein Gold results in increased expression of CASP3 mRNA |
CTD |
PMID:19760634 PMID:21621595 PMID:22178767 PMID:25846798 PMID:26551149 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP4 |
caspase 4 |
increases cleavage |
EXP |
Gold analog results in increased cleavage of CASP4 protein |
CTD |
PMID:26551149 |
|
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
|
|
G |
CASP7 |
caspase 7 |
increases cleavage |
EXP |
Gold analog results in increased cleavage of CASP7 protein |
CTD |
PMID:26551149 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
increases expression decreases expression |
EXP |
Gold results in increased expression of CASP8 mRNA Gold analog results in decreased expression of CASP8 mRNA |
CTD |
PMID:22178767 PMID:36057382 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases cleavage |
EXP ISO |
[Gold analog co-treated with Platinum] results in increased activity of CASP9 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA Gold analog results in increased cleavage of CASP9 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein |
CTD |
PMID:25846798 PMID:26551149 PMID:27836789 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein] |
CTD |
PMID:27836789 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CBX3 |
chromobox 3 |
decreases expression |
EXP |
Gold results in decreased expression of CBX3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:26,201,443...26,213,607
Ensembl chr 7:26,201,162...26,213,607
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein Gold results in increased secretion of CCL2 protein |
CTD |
PMID:22155353 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein Gold results in increased secretion of CCL5 protein |
CTD |
PMID:22155353 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL7 protein Gold results in increased secretion of CCL7 protein |
CTD |
PMID:22155353 |
|
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in decreased expression of CCND1 protein |
CTD |
PMID:27470402 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCT5 |
chaperonin containing TCP1 subunit 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of CCT5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 5:10,249,921...10,266,412
Ensembl chr 5:10,249,929...10,266,389
|
|
G |
CD19 |
CD19 molecule |
increases expression |
EXP |
Gold analog results in increased expression of CD19 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:28,931,971...28,939,342
Ensembl chr16:28,931,965...28,939,342
|
|
G |
CD36 |
CD36 molecule (CD36 blood group) |
decreases expression |
EXP |
Gold analog results in decreased expression of CD36 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
|
|
G |
CD40 |
CD40 molecule |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CD40 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD86 |
CD86 molecule |
decreases expression |
EXP |
Gold analog results in decreased expression of CD86 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CDA |
cytidine deaminase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,589,086...20,618,903
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
decreases expression increases expression |
EXP |
Gold results in decreased expression of CDK1 mRNA Gold results in increased expression of CDK1 mRNA |
CTD |
PMID:25523186 PMID:29705079 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CDK7 |
cyclin dependent kinase 7 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CDK7 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:69,234,795...69,277,430
Ensembl chr 5:69,234,795...69,277,430
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
EXP |
[Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein |
CTD |
PMID:17079469 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN2AIP |
CDKN2A interacting protein |
decreases expression |
EXP |
Gold results in decreased expression of CDKN2AIP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:183,444,636...183,449,064
Ensembl chr 4:183,444,635...183,449,064
|
|
G |
CGRRF1 |
cell growth regulator with ring finger domain 1 |
decreases expression |
EXP |
Gold results in decreased expression of CGRRF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:54,509,906...54,539,292
Ensembl chr14:54,509,812...54,539,292
|
|
G |
CHEK1 |
checkpoint kinase 1 |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CHEK1 mRNA Gold analog results in decreased expression of CHEK1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
|
|
G |
CHEK2 |
checkpoint kinase 2 |
decreases expression |
EXP |
Gold analog results in decreased expression of CHEK2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
|
|
G |
CHORDC1 |
cysteine and histidine rich domain containing 1 |
decreases expression |
EXP |
Gold results in decreased expression of CHORDC1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:90,200,429...90,223,049
Ensembl chr11:90,200,429...90,223,077
|
|
G |
CISD1 |
CDGSH iron sulfur domain 1 |
decreases expression |
EXP |
Gold results in decreased expression of CISD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:58,269,162...58,289,586
Ensembl chr10:58,269,162...58,289,586
|
|
G |
CLDN12 |
claudin 12 |
decreases expression |
EXP |
Gold results in decreased expression of CLDN12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:90,403,461...90,415,954
Ensembl chr 7:90,383,721...90,513,402
|
|
G |
CNBP |
CCHC-type zinc finger nucleic acid binding protein |
decreases expression |
EXP |
Gold results in decreased expression of CNBP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:129,167,827...129,183,896
Ensembl chr 3:129,167,827...129,183,922
|
|
G |
CNOT7 |
CCR4-NOT transcription complex subunit 7 |
decreases expression |
EXP |
Gold results in decreased expression of CNOT7 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:17,224,966...17,246,857
Ensembl chr 8:17,224,966...17,246,878
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
Gold analog results in increased expression of COL1A1 protein |
CTD |
PMID:24780912 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL1A2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL3A1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
COMMD8 |
COMM domain containing 8 |
decreases expression |
EXP |
Gold results in decreased expression of COMMD8 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:47,450,787...47,463,702
Ensembl chr 4:47,450,787...47,463,702
|
|
G |
COX11 |
cytochrome c oxidase copper chaperone COX11 |
decreases expression |
EXP |
Gold results in decreased expression of COX11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:54,951,902...54,968,785
Ensembl chr17:54,951,902...54,968,703
|
|
G |
COX17 |
cytochrome c oxidase copper chaperone COX17 |
decreases expression |
EXP |
Gold results in decreased expression of COX17 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:119,663,975...119,677,406
Ensembl chr 3:119,654,513...119,677,454
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
|
|
G |
CPT2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197
|
|
G |
CROT |
carnitine O-octanoyltransferase |
decreases expression |
EXP |
Gold analog results in decreased expression of CROT mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:87,345,664...87,399,794
Ensembl chr 7:87,345,664...87,399,794
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein Gold results in increased secretion of CSF2 protein |
CTD |
PMID:22155353 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CSF3 |
colony stimulating factor 3 |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of CSF3 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF3 protein |
CTD |
PMID:22155353 |
|
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
|
|
G |
CTCF |
CCCTC-binding factor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CTCF mRNA |
CTD |
PMID:19695318 |
|
NCBI chr16:67,562,526...67,639,185
Ensembl chr16:67,562,467...67,639,177
|
|
G |
CUX1 |
cut like homeobox 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CUX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:101,816,007...102,283,958
Ensembl chr 7:101,815,904...102,283,958
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of CXCL10 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein |
CTD |
PMID:22155353 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL2 mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL2 protein Gold results in increased secretion of CXCL2 protein |
CTD |
PMID:19695318 PMID:22155353 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CYCS |
cytochrome c, somatic |
multiple interactions |
EXP |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of CYCS protein |
CTD |
PMID:21621595 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases activity decreases expression multiple interactions |
ISO EXP |
Gold analog results in increased activity of CYP1A1 protein Gold analog results in decreased expression of CYP1A1 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:20193702 PMID:28433809 PMID:36057382 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP24A1 |
cytochrome P450 family 24 subfamily A member 1 |
increases expression |
EXP |
Gold results in increased expression of CYP24A1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr20:54,143,538...54,173,986
Ensembl chr20:54,153,446...54,173,986
|
|
G |
CYP2D6 |
cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene) |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CYP2D6 mRNA Gold analog results in decreased expression of CYP2D6 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
EXP |
Gold analog results in increased expression of CYP7A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
CYTH1 |
cytohesin 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CYTH1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:78,674,048...78,782,273
Ensembl chr17:78,674,048...78,782,297
|
|
G |
DAB2 |
DAB adaptor protein 2 |
increases expression |
EXP |
Gold results in increased expression of DAB2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300
|
|
G |
DCP2 |
decapping mRNA 2 |
decreases expression |
EXP |
Gold results in decreased expression of DCP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:112,976,798...113,022,195
Ensembl chr 5:112,976,702...113,022,195
|
|
G |
DDC |
dopa decarboxylase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DDC mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of DDIT3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of DDIT4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
|
G |
DEFB1 |
defensin beta 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of DEFB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936
|
|
G |
DHCR24 |
24-dehydrocholesterol reductase |
multiple interactions decreases expression |
ISO EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DHCR24 mRNA Gold analog results in decreased expression of DHCR24 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of DHCR24 mRNA |
CTD |
PMID:19695318 PMID:28433809 PMID:36057382 |
|
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
|
|
G |
DLD |
dihydrolipoamide dehydrogenase |
decreases expression |
EXP |
Gold analog results in decreased expression of DLD mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:107,891,107...107,921,198
Ensembl chr 7:107,891,162...107,931,730
|
|
G |
DNAH14 |
dynein axonemal heavy chain 14 |
decreases expression |
EXP |
Gold results in decreased expression of DNAH14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:224,929,654...225,399,286
Ensembl chr 1:224,896,262...225,399,292
|
|
G |
DNAJA3 |
DnaJ heat shock protein family (Hsp40) member A3 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of DNAJA3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:4,425,868...4,456,775
Ensembl chr16:4,425,805...4,456,775
|
|
G |
DNAJB14 |
DnaJ heat shock protein family (Hsp40) member B14 |
decreases expression |
EXP |
Gold results in decreased expression of DNAJB14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:99,896,248...99,946,618
Ensembl chr 4:99,896,248...99,946,618
|
|
G |
DNAJB6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases expression |
EXP |
Gold results in decreased expression of DNAJB6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:157,337,004...157,417,439
Ensembl chr 7:157,335,381...157,417,439
|
|
G |
DNAJB9 |
DnaJ heat shock protein family (Hsp40) member B9 |
decreases expression |
EXP |
Gold results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
|
|
G |
DNAJC10 |
DnaJ heat shock protein family (Hsp40) member C10 |
decreases expression |
EXP |
Gold results in decreased expression of DNAJC10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:182,716,257...182,794,464
Ensembl chr 2:182,716,255...182,794,464
|
|
G |
DNAJC19 |
DnaJ heat shock protein family (Hsp40) member C19 |
decreases expression |
EXP |
Gold results in decreased expression of DNAJC19 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:180,983,709...180,989,838
Ensembl chr 3:180,983,697...180,989,774
|
|
G |
DNAJC21 |
DnaJ heat shock protein family (Hsp40) member C21 |
decreases expression |
EXP |
Gold results in decreased expression of DNAJC21 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:34,929,559...34,958,964
Ensembl chr 5:34,929,559...34,958,964
|
|
G |
DNAJC5 |
DnaJ heat shock protein family (Hsp40) member C5 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of DNAJC5 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr20:63,895,126...63,936,011
Ensembl chr20:63,895,126...63,936,031
|
|
G |
DPYSL4 |
dihydropyrimidinase like 4 |
increases expression |
EXP |
Gold analog results in increased expression of DPYSL4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:132,186,948...132,205,759
Ensembl chr10:132,186,948...132,205,759
|
|
G |
DRD3 |
dopamine receptor D3 |
multiple interactions |
ISO |
Gold inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] |
CTD |
PMID:10215675 |
|
NCBI chr 3:114,127,580...114,199,407
Ensembl chr 3:114,127,580...114,199,407
|
|
G |
DRD4 |
dopamine receptor D4 |
multiple interactions |
ISO |
Gold inhibits the reaction [3-N-methylspiperone binds to DRD4 protein] |
CTD |
PMID:10215675 |
|
NCBI chr11:637,269...640,706
Ensembl chr11:637,269...640,706
|
|
G |
DSC2 |
desmocollin 2 |
increases expression |
EXP |
Gold results in increased expression of DSC2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600
|
|
G |
DSG2 |
desmoglein 2 |
increases expression |
EXP |
Gold results in increased expression of DSG2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr18:31,498,177...31,549,008
Ensembl chr18:31,497,624...31,551,351
|
|
G |
DUOX1 |
dual oxidase 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of DUOX1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr15:45,129,994...45,165,574
Ensembl chr15:45,129,933...45,165,576
|
|
G |
DUOX2 |
dual oxidase 2 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of DUOX2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr15:45,092,650...45,114,172
Ensembl chr15:45,092,650...45,114,172
|
|
G |
DUSP1 |
dual specificity phosphatase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of DUSP1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
|
|
G |
DUSP11 |
dual specificity phosphatase 11 |
decreases expression |
EXP |
Gold results in decreased expression of DUSP11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:73,762,213...73,780,149
Ensembl chr 2:73,761,782...73,780,173
|
|
G |
DUT |
deoxyuridine triphosphatase |
decreases expression |
EXP |
Gold results in decreased expression of DUT mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:48,331,095...48,343,373
Ensembl chr15:48,331,011...48,343,373
|
|
G |
DZIP3 |
DAZ interacting zinc finger protein 3 |
decreases expression |
EXP |
Gold results in decreased expression of DZIP3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:108,589,510...108,694,840
Ensembl chr 3:108,589,705...108,694,840
|
|
G |
EDEM3 |
ER degradation enhancing alpha-mannosidase like protein 3 |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of EDEM3 mRNA Gold analog results in decreased expression of EDEM3 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 1:184,690,237...184,754,858
Ensembl chr 1:184,690,237...184,754,907
|
|
G |
EEA1 |
early endosome antigen 1 |
decreases expression |
EXP |
Gold results in decreased expression of EEA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:92,770,637...92,929,295
Ensembl chr12:92,770,637...92,929,331
|
|
G |
EEF1D |
eukaryotic translation elongation factor 1 delta |
decreases expression |
ISO |
Gold analog results in decreased expression of EEF1D protein |
CTD |
PMID:24780912 |
|
NCBI chr 8:143,579,728...143,597,415
Ensembl chr 8:143,579,697...143,599,541
|
|
G |
EEF2 |
eukaryotic translation elongation factor 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of EEF2 protein |
CTD |
PMID:24780912 |
|
NCBI chr19:3,976,056...3,985,463
Ensembl chr19:3,976,056...3,985,463
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein]; EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:27634460 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EHHADH |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
decreases expression |
EXP |
Gold analog results in decreased expression of EHHADH mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:185,190,624...185,254,049
Ensembl chr 3:185,190,624...185,281,990
|
|
G |
EID1 |
EP300 interacting inhibitor of differentiation 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of EID1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr15:48,878,134...48,880,173
Ensembl chr15:48,878,134...48,880,173
|
|
G |
EIF1AX |
eukaryotic translation initiation factor 1A X-linked |
decreases expression |
EXP |
Gold results in decreased expression of EIF1AX mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:20,124,525...20,141,838
Ensembl chr X:20,124,525...20,141,838
|
|
G |
EIF1AY |
eukaryotic translation initiation factor 1A Y-linked |
decreases expression |
EXP |
Gold results in decreased expression of EIF1AY mRNA |
CTD |
PMID:25523186 |
|
NCBI chr Y:20,575,776...20,593,154
Ensembl chr Y:20,575,776...20,593,154
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation |
EXP |
Gold analog results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:26551149 |
|
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
EIF4A2 |
eukaryotic translation initiation factor 4A2 |
decreases expression |
EXP |
Gold results in decreased expression of EIF4A2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:186,783,577...186,789,897
Ensembl chr 3:186,783,205...186,789,897
|
|
G |
EIF4E |
eukaryotic translation initiation factor 4E |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in decreased expression of EIF4E protein |
CTD |
PMID:27470402 |
|
NCBI chr 4:98,879,276...98,929,133
Ensembl chr 4:98,879,276...98,929,133
|
|
G |
EIF4EBP3 |
eukaryotic translation initiation factor 4E binding protein 3 |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in increased expression of EIF4EBP3 protein |
CTD |
PMID:27470402 |
|
NCBI chr 5:140,547,662...140,549,576
Ensembl chr 5:140,547,662...140,549,576
|
|
G |
EIF5B |
eukaryotic translation initiation factor 5B |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of EIF5B mRNA Gold analog results in decreased expression of EIF5B mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 2:99,337,389...99,401,326
Ensembl chr 2:99,337,389...99,401,326
|
|
G |
ENO1 |
enolase 1 |
multiple interactions |
ISO |
Gold analog results in decreased expression of and results in increased phosphorylation of ENO1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
|
|
G |
EP300 |
E1A binding protein p300 |
multiple interactions |
EXP |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein]; [Polyethyleneimine binds to Gold] which results in decreased expression of EP300 mRNA; EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]] |
CTD |
PMID:27634460 PMID:28433809 |
|
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,510...41,180,077
|
|
G |
EPGN |
epithelial mitogen |
increases expression |
EXP |
Gold results in increased expression of EPGN mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 4:74,308,470...74,316,789
Ensembl chr 4:74,308,470...74,316,789
|
|
G |
EPHA1 |
EPH receptor A1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of EPHA1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:143,391,129...143,408,856
Ensembl chr 7:143,390,289...143,408,856
|
|
G |
EPHX1 |
epoxide hydrolase 1 |
increases expression |
EXP |
Gold analog results in increased expression of EPHX1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
|
|
G |
ERCC2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ERCC2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
|
|
G |
ERCC6 |
ERCC excision repair 6, chromatin remodeling factor |
decreases expression |
EXP |
Gold analog results in decreased expression of ERCC6 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:49,434,881...49,539,538
Ensembl chr10:49,454,168...49,539,538
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
increases phosphorylation |
EXP |
Gold analog results in increased phosphorylation of ERN1 protein |
CTD |
PMID:26551149 |
|
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
|
|
G |
ERN2 |
endoplasmic reticulum to nucleus signaling 2 |
increases expression |
EXP |
Gold analog results in increased expression of ERN2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:23,690,310...23,713,222
Ensembl chr16:23,690,310...23,713,226
|
|
G |
ERO1A |
endoplasmic reticulum oxidoreductase 1 alpha |
increases expression |
EXP |
Gold results in increased expression of ERO1A mRNA |
CTD |
PMID:29705079 |
|
NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
|
|
G |
ESCO2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
decreases expression |
EXP |
Gold results in decreased expression of ESCO2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:27,771,974...27,819,660
Ensembl chr 8:27,771,949...27,812,640
|
|
G |
ESR1 |
estrogen receptor 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of ESR1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
EVI5 |
ecotropic viral integration site 5 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of EVI5 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:92,508,696...92,792,410
Ensembl chr 1:92,508,696...92,792,404
|
|
G |
EVX1 |
even-skipped homeobox 1 |
increases expression |
EXP |
Gold results in increased expression of EVX1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:27,242,802...27,247,830
Ensembl chr 7:27,242,700...27,250,493
|
|
G |
FANCL |
FA complementation group L |
decreases expression |
EXP |
Gold results in decreased expression of FANCL mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:58,159,243...58,241,380
Ensembl chr 2:58,159,243...58,241,410
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of FAS mRNA Gold analog results in decreased expression of FAS mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASN |
fatty acid synthase |
decreases expression |
EXP |
Gold analog results in decreased expression of FASN mRNA |
CTD |
PMID:36057382 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FGF1 |
fibroblast growth factor 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of FGF1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
|
|
G |
FH |
fumarate hydratase |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of FH mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:241,497,603...241,519,755
Ensembl chr 1:241,497,511...241,519,799
|
|
G |
FKBP9 |
FKBP prolyl isomerase 9 |
increases phosphorylation decreases expression |
ISO |
Gold analog results in increased phosphorylation of FKBP9 protein Gold analog results in decreased expression of FKBP9 protein |
CTD |
PMID:24780912 |
|
NCBI chr 7:32,957,440...33,006,928
Ensembl chr 7:32,957,404...33,006,930
|
|
G |
FMO5 |
flavin containing dimethylaniline monoxygenase 5 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of FMO5 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:147,184,305...147,227,284
Ensembl chr 1:147,175,351...147,243,050
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased expression of FOS mRNA Gold results in increased expression of FOS mRNA |
CTD |
PMID:22155353 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
FTH1 |
ferritin heavy chain 1 |
increases expression |
EXP |
Gold results in increased expression of FTH1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
|
|
G |
FYB1 |
FYN binding protein 1 |
increases expression |
EXP |
Gold results in increased expression of FYB1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:39,105,252...39,274,528
Ensembl chr 5:39,105,252...39,274,528
|
|
G |
FZD4 |
frizzled class receptor 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of FZD4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:86,945,679...86,955,395
Ensembl chr11:86,945,679...86,955,395
|
|
G |
G2E3 |
G2/M-phase specific E3 ubiquitin protein ligase |
decreases expression |
EXP |
Gold results in decreased expression of G2E3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:30,559,158...30,620,064
Ensembl chr14:30,559,158...30,620,064
|
|
G |
GALNT1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
decreases expression |
EXP |
Gold results in decreased expression of GALNT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:35,580,922...35,711,834
Ensembl chr18:35,581,117...35,711,834
|
|
G |
GALNT5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
decreases expression |
EXP |
Gold analog results in decreased expression of GALNT5 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:157,257,705...157,318,491
Ensembl chr 2:157,257,705...157,318,491
|
|
G |
GANC |
glucosidase alpha, neutral C |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of GANC mRNA |
CTD |
PMID:19695318 |
|
NCBI chr15:42,273,201...42,353,666
Ensembl chr15:42,273,201...42,353,666
|
|
G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
decreases expression |
ISO |
Gold analog results in decreased expression of GAPDH protein |
CTD |
PMID:24780912 |
|
NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
|
|
G |
GCA |
grancalcin |
decreases expression |
EXP |
Gold results in decreased expression of GCA mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:162,318,763...162,375,396
Ensembl chr 2:162,318,840...162,371,595
|
|
G |
GCDH |
glutaryl-CoA dehydrogenase |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of GCDH mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:12,891,129...12,899,999
Ensembl chr19:12,891,128...12,915,126
|
|
G |
GMPS |
guanine monophosphate synthase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of GMPS mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:155,869,430...155,944,020
Ensembl chr 3:155,870,650...155,944,020
|
|
G |
GNG10 |
G protein subunit gamma 10 |
decreases expression |
EXP |
Gold results in decreased expression of GNG10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:111,661,605...111,670,226
Ensembl chr 9:111,661,605...111,670,226
|
|
G |
GOT2 |
glutamic-oxaloacetic transaminase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of GOT2 protein |
CTD |
PMID:24780912 |
|
NCBI chr16:58,707,131...58,734,316
Ensembl chr16:58,707,131...58,734,342
|
|
G |
GPR182 |
G protein-coupled receptor 182 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of GPR182 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:56,994,492...56,998,877
Ensembl chr12:56,994,492...56,998,447
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions decreases expression |
ISO EXP |
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in increased activity of GPT protein]; [Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in increased expression of GPT protein] Gold analog results in decreased expression of GPT mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of GPT mRNA |
CTD |
PMID:27836789 PMID:28433809 PMID:36057382 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPX2 |
glutathione peroxidase 2 |
increases expression |
EXP |
Gold analog results in increased expression of GPX2 mRNA; Gold results in increased expression of GPX2 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
|
|
G |
GPX3 |
glutathione peroxidase 3 |
increases expression |
EXP |
Gold analog results in increased expression of GPX3 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
|
|
G |
GSN |
gelsolin |
decreases expression increases degradation |
ISO EXP |
Gold analog results in decreased expression of GSN protein Gold analog results in increased degradation of GSN protein |
CTD |
PMID:24780912 PMID:26551149 |
|
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
|
|
G |
GSTM4 |
glutathione S-transferase mu 4 |
multiple interactions increases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of GSTM4 mRNA Gold analog results in increased expression of GSTM4 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496
|
|
G |
GTF2H2C_2 |
GTF2H2 family member C, copy 2 |
decreases expression |
EXP |
Gold results in decreased expression of GTF2H2C_2 mRNA |
CTD |
PMID:25523186 |
|
|
|
G |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
increases expression |
EXP |
Gold analog results in increased expression of HAAO mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:42,767,089...42,792,583
Ensembl chr 2:42,767,089...42,792,593
|
|
G |
HAT1 |
histone acetyltransferase 1 |
decreases expression |
EXP |
Gold results in decreased expression of HAT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:171,922,461...171,983,686
Ensembl chr 2:171,922,448...171,983,686
|
|
G |
HAVCR1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
EXP |
[Polyethylene Glycols binds to Gold] which results in increased expression of HAVCR1 protein; [Polyethyleneimine binds to Gold] which results in increased expression of HAVCR1 protein; [Thioctic Acid binds to Gold] which results in increased expression of HAVCR1 protein |
CTD |
PMID:28433809 |
|
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
|
|
G |
HCAR2 |
hydroxycarboxylic acid receptor 2 |
increases expression |
EXP |
Gold results in increased expression of HCAR2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr12:122,701,293...122,703,357
Ensembl chr12:122,701,293...122,703,357
|
|
G |
HEXB |
hexosaminidase subunit beta |
multiple interactions |
ISO |
[gold chloride results in increased abundance of Gold] which results in increased export of HEXB protein; [gold tetrachloride, acid results in increased abundance of Gold] which results in increased export of HEXB protein |
CTD |
PMID:21376117 |
|
NCBI chr 5:74,640,023...74,721,288
Ensembl chr 5:74,640,023...74,722,647
|
|
G |
HLA-B |
major histocompatibility complex, class I, B |
affects response to substance |
EXP |
HLA-B gene polymorphism affects the susceptibility to Gold |
CTD |
PMID:3084782 |
|
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
|
|
G |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
increases expression |
EXP |
Gold analog results in increased expression of HLA-DRB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
|
|
G |
HMGB2 |
high mobility group box 2 |
decreases expression |
EXP |
Gold results in decreased expression of HMGB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,432
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
EXP |
Gold results in increased expression of HMOX1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HOXA3 |
homeobox A3 |
decreases expression |
EXP |
Gold analog results in decreased expression of HOXA3 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:27,107,010...27,152,583
Ensembl chr 7:27,106,184...27,152,583
|
|
G |
HPRT1 |
hypoxanthine phosphoribosyltransferase 1 |
decreases expression |
EXP |
Gold results in decreased expression of HPRT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:134,460,165...134,500,668
Ensembl chr X:134,460,165...134,520,513
|
|
G |
HPX |
hemopexin |
decreases expression |
EXP |
Gold analog results in decreased expression of HPX mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617
|
|
G |
HSBP1 |
heat shock factor binding protein 1 |
decreases expression |
EXP |
Gold results in decreased expression of HSBP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:83,807,978...83,819,737
Ensembl chr16:83,719,311...83,819,737
|
|
G |
HSF1 |
heat shock transcription factor 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of HSF1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
|
|
G |
HSP90AB1 |
heat shock protein 90 alpha family class B member 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSP90AB1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
|
|
G |
HSPA13 |
heat shock protein family A (Hsp70) member 13 |
decreases expression |
EXP |
Gold results in decreased expression of HSPA13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr21:14,371,115...14,383,146
Ensembl chr21:14,371,115...14,383,484
|
|
G |
HSPA1A |
heat shock protein family A (Hsp70) member 1A |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of HSPA1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
|
|
G |
HSPA1B |
heat shock protein family A (Hsp70) member 1B |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of HSPA1B mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
|
|
G |
HSPA2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression |
EXP |
Gold analog results in decreased expression of HSPA2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
|
|
G |
HSPA4 |
heat shock protein family A (Hsp70) member 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSPA4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
ISO |
Gold analog results in increased expression of HSPA8 protein |
CTD |
PMID:24780912 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
HSPA9 |
heat shock protein family A (Hsp70) member 9 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of HSPA9 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:138,553,756...138,575,401
Ensembl chr 5:138,553,756...138,575,675
|
|
G |
HSPB1 |
heat shock protein family B (small) member 1 |
multiple interactions |
ISO EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSPB1 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of HSPB1 mRNA |
CTD |
PMID:19695318 PMID:28433809 |
|
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,305,813
|
|
G |
HSPD1 |
heat shock protein family D (Hsp60) member 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of HSPD1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
|
|
G |
HTATIP2 |
HIV-1 Tat interactive protein 2 |
increases expression |
EXP |
Gold results in increased expression of HTATIP2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr11:20,363,714...20,383,782
Ensembl chr11:20,363,685...20,383,782
|
|
G |
HTATSF1 |
HIV-1 Tat specific factor 1 |
decreases expression |
EXP |
Gold results in decreased expression of HTATSF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:136,497,229...136,512,346
Ensembl chr X:136,497,079...136,512,346
|
|
G |
HTRA4 |
HtrA serine peptidase 4 |
decreases expression |
EXP |
Gold analog results in decreased expression of HTRA4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:38,974,228...38,988,663
Ensembl chr 8:38,974,228...38,988,663
|
|
G |
HYOU1 |
hypoxia up-regulated 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of HYOU1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:119,044,188...119,057,205
Ensembl chr11:119,044,188...119,057,227
|
|
G |
IDH1 |
isocitrate dehydrogenase (NADP(+)) 1 |
multiple interactions |
ISO |
Gold analog results in decreased expression of and results in increased phosphorylation of IDH1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
|
|
G |
IDH3G |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of IDH3G mRNA |
CTD |
PMID:28433809 |
|
NCBI chr X:153,785,768...153,794,375
Ensembl chr X:153,785,766...153,794,512
|
|
G |
IFNGR1 |
interferon gamma receptor 1 |
increases expression |
EXP |
Gold results in increased expression of IFNGR1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
|
|
G |
IGF1 |
insulin like growth factor 1 |
multiple interactions |
EXP |
Gold inhibits the reaction [IGF1 protein binds to IGF1R protein] |
CTD |
PMID:9648927 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGF1R |
insulin like growth factor 1 receptor |
multiple interactions |
EXP |
Gold inhibits the reaction [IGF1 protein binds to IGF1R protein]; Gold inhibits the reaction [IGF2 protein binds to IGF1R protein] |
CTD |
PMID:9648927 |
|
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
|
|
G |
IGF2 |
insulin like growth factor 2 |
multiple interactions |
EXP |
Gold inhibits the reaction [IGF2 protein binds to IGF1R protein] |
CTD |
PMID:9648927 |
|
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
|
|
G |
IKZF2 |
IKAROS family zinc finger 2 |
decreases expression |
EXP |
Gold results in decreased expression of IKZF2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:212,999,698...213,152,456
Ensembl chr 2:212,999,691...213,152,427
|
|
G |
IL10 |
interleukin 10 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of IL10 protein Gold results in increased secretion of IL10 protein |
CTD |
PMID:22155353 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions decreases expression increases secretion |
ISO EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of IL1A protein Gold analog results in decreased expression of IL1A mRNA Gold results in increased secretion of IL1A protein |
CTD |
PMID:22155353 PMID:36057382 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions decreases expression increases secretion |
ISO EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of IL1B mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of IL1B protein Gold analog results in decreased expression of IL1B mRNA Gold results in increased secretion of IL1B protein |
CTD |
PMID:19695318 PMID:22155353 PMID:36057382 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL4 |
interleukin 4 |
decreases expression |
EXP |
Gold analog results in decreased expression of IL4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL6 |
interleukin 6 |
multiple interactions increases secretion |
ISO EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of IL6 mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of IL6 protein [Polyethylene Glycols binds to Gold] which results in increased expression of IL6 protein; [Polyethyleneimine binds to Gold] which results in increased expression of IL6 protein; [Thioctic Acid binds to Gold] which results in increased expression of IL6 protein Gold results in increased secretion of IL6 protein |
CTD |
PMID:19695318 PMID:22155353 PMID:28433809 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IL6R |
interleukin 6 receptor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of IL6RA mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
|
|
G |
IMPA1 |
inositol monophosphatase 1 |
decreases expression |
EXP |
Gold results in decreased expression of IMPA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:81,656,914...81,686,325
Ensembl chr 8:81,656,914...81,686,331
|
|
G |
IPMK |
inositol polyphosphate multikinase |
decreases expression |
EXP |
Gold results in decreased expression of IPMK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:58,191,517...58,267,894
Ensembl chr10:58,191,517...58,267,894
|
|
G |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of IQGAP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:76,403,285...76,708,132
Ensembl chr 5:76,403,285...76,708,132
|
|
G |
JAG1 |
jagged canonical Notch ligand 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of JAG1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
|
|
G |
JAK2 |
Janus kinase 2 |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of JAK2 protein |
CTD |
PMID:27470402 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
JUP |
junction plakoglobin |
decreases expression |
ISO |
Gold analog results in decreased expression of JUP protein |
CTD |
PMID:24780912 |
|
NCBI chr17:41,754,609...41,786,711
Ensembl chr17:41,754,604...41,786,931
|
|
G |
KHK |
ketohexokinase |
increases expression |
EXP |
Gold analog results in increased expression of KHK mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:27,086,772...27,100,762
Ensembl chr 2:27,086,772...27,100,762
|
|
G |
KIN |
Kin17 DNA and RNA binding protein |
decreases expression |
EXP |
Gold results in decreased expression of KIN mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:7,750,962...7,787,993
Ensembl chr10:7,750,962...7,787,993
|
|
G |
KITLG |
KIT ligand |
decreases expression |
EXP |
Gold results in decreased expression of KITLG mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
|
|
G |
KRR1 |
KRR1 small subunit processome component homolog |
decreases expression |
EXP |
Gold results in decreased expression of KRR1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:75,490,863...75,511,609
Ensembl chr12:75,490,863...75,511,636
|
|
G |
KYNU |
kynureninase |
increases expression |
EXP |
Gold results in increased expression of KYNU mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:142,877,664...143,055,833
Ensembl chr 2:142,877,657...143,055,833
|
|
G |
LACC1 |
laccase domain containing 1 |
increases expression |
EXP |
Gold results in increased expression of LACC1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr13:43,879,178...43,893,932
Ensembl chr13:43,879,284...43,893,932
|
|
G |
LACTB2 |
lactamase beta 2 |
decreases expression |
EXP |
Gold results in decreased expression of LACTB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:70,637,266...70,669,185
Ensembl chr 8:70,635,318...70,669,185
|
|
G |
LARP1B |
La ribonucleoprotein 1B |
decreases expression |
EXP |
Gold results in decreased expression of LARP1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:128,060,789...128,222,926
Ensembl chr 4:128,061,286...128,222,931
|
|
G |
LIF |
LIF interleukin 6 family cytokine |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of LIF protein Gold results in increased secretion of LIF protein |
CTD |
PMID:22155353 |
|
NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759
|
|
G |
LIG4 |
DNA ligase 4 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which affects the expression of LIG4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr13:108,207,442...108,218,349
Ensembl chr13:108,207,439...108,218,368
|
|
G |
LIMA1 |
LIM domain and actin binding 1 |
decreases expression |
EXP |
Gold results in decreased expression of LIMA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:50,175,788...50,283,520
Ensembl chr12:50,175,788...50,283,520
|
|
G |
LMAN1 |
lectin, mannose binding 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of LMAN1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:59,327,823...59,359,265
Ensembl chr18:59,327,823...59,359,265
|
|
G |
LMNA |
lamin A/C |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of LMNA mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:156,082,573...156,140,081
Ensembl chr 1:156,082,572...156,140,081
|
|
G |
LMNB1 |
lamin B1 |
increases degradation |
EXP |
Gold analog results in increased degradation of LMNB1 protein |
CTD |
PMID:26551149 |
|
NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
|
|
G |
LPGAT1 |
lysophosphatidylglycerol acyltransferase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of LPGAT1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:211,743,457...211,830,763
Ensembl chr 1:211,743,457...211,830,763
|
|
G |
LRATD1 |
LRAT domain containing 1 |
increases expression |
EXP |
Gold results in increased expression of LRATD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:14,632,717...14,651,916
Ensembl chr 2:14,632,700...14,650,814
|
|
G |
LSM5 |
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
EXP |
Gold results in decreased expression of LSM5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:32,485,338...32,495,283
Ensembl chr 7:32,485,338...32,495,283
|
|
G |
LSM6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
EXP |
Gold results in decreased expression of LSM6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:146,175,718...146,191,535
Ensembl chr 4:146,175,703...146,200,000
|
|
G |
LSS |
lanosterol synthase |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of LSS mRNA |
CTD |
PMID:28433809 |
|
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
|
|
G |
MAD2L1 |
mitotic arrest deficient 2 like 1 |
decreases expression |
EXP |
Gold results in decreased expression of MAD2L1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:120,055,623...120,066,848
Ensembl chr 4:120,055,623...120,066,858
|
|
G |
MAP1B |
microtubule associated protein 1B |
increases expression |
EXP |
Gold results in increased expression of MAP1B mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:72,107,475...72,209,565
Ensembl chr 5:72,107,234...72,209,565
|
|
G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
multiple interactions |
EXP |
MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]] |
CTD |
PMID:27634460 |
|
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
|
|
G |
MBNL2 |
muscleblind like splicing regulator 2 |
decreases expression |
EXP |
Gold results in decreased expression of MBNL2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:97,141,834...97,394,120
Ensembl chr13:97,221,434...97,394,120
|
|
G |
MDH1B |
malate dehydrogenase 1B |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of MDH1B mRNA Gold analog results in decreased expression of MDH1B mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 2:206,737,763...206,765,328
Ensembl chr 2:206,737,763...206,765,328
|
|
G |
MDM2 |
MDM2 proto-oncogene |
decreases expression |
EXP |
Gold analog results in decreased expression of MDM2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
|
|
G |
MECR |
mitochondrial trans-2-enoyl-CoA reductase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of MECR mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:29,167,696...29,230,934
Ensembl chr 1:29,192,657...29,230,942
|
|
G |
MEFV |
MEFV innate immunity regulator, pyrin |
increases expression |
EXP |
Gold results in increased expression of MEFV mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:3,242,027...3,256,633
Ensembl chr16:3,242,027...3,256,633
|
|
G |
METAP2 |
methionyl aminopeptidase 2 |
decreases expression |
EXP |
Gold analog results in decreased expression of METAP2 mRNA; Gold results in decreased expression of METAP2 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr12:95,474,152...95,515,839
Ensembl chr12:95,473,520...95,515,839
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of MKI67 mRNA Gold analog results in decreased expression of MKI67 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MMGT1 |
membrane magnesium transporter 1 |
decreases expression |
EXP |
Gold results in decreased expression of MMGT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:135,960,588...135,973,988
Ensembl chr X:135,960,588...135,974,029
|
|
G |
MMP3 |
matrix metallopeptidase 3 |
increases expression |
EXP |
Gold results in increased expression of MMP3 mRNA |
CTD |
PMID:24022940 |
|
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]; EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]] |
CTD |
PMID:27634460 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MNAT1 |
MNAT1 component of CDK activating kinase |
decreases expression |
EXP |
Gold results in decreased expression of MNAT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:60,734,761...60,969,965
Ensembl chr14:60,734,742...60,969,965
|
|
G |
MOB1B |
MOB kinase activator 1B |
decreases expression |
EXP |
Gold results in decreased expression of MOB1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:70,901,851...70,988,168
Ensembl chr 4:70,902,326...71,022,449
|
|
G |
MOB4 |
MOB family member 4, phocein |
decreases expression |
EXP |
Gold results in decreased expression of MOB4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:197,515,554...197,553,699
Ensembl chr 2:197,515,571...197,553,699
|
|
G |
MORC3 |
MORC family CW-type zinc finger 3 |
decreases expression |
EXP |
Gold results in decreased expression of MORC3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr21:36,320,197...36,376,632
Ensembl chr21:36,320,189...36,386,148
|
|
G |
MRPL3 |
mitochondrial ribosomal protein L3 |
decreases expression |
EXP |
Gold results in decreased expression of MRPL3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:131,462,212...131,502,971
Ensembl chr 3:131,462,212...131,502,983
|
|
G |
MRPS6 |
mitochondrial ribosomal protein S6 |
decreases expression |
EXP |
Gold results in decreased expression of MRPS6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr21:34,073,578...34,143,030
Ensembl chr21:34,073,224...34,362,252
|
|
G |
MT1B |
metallothionein 1B |
increases expression |
EXP |
Gold results in increased expression of MT1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:56,651,886...56,653,204
Ensembl chr16:56,651,886...56,653,204
|
|
G |
MT1E |
metallothionein 1E |
increases expression |
EXP |
Gold results in increased expression of MT1E mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:56,625,781...56,627,112
Ensembl chr16:56,625,475...56,627,112
|
|
G |
MT1F |
metallothionein 1F |
increases expression |
EXP |
Gold results in increased expression of MT1F mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:56,657,959...56,659,303
Ensembl chr16:56,657,731...56,660,698
|
|
G |
MT1H |
metallothionein 1H |
increases expression |
EXP |
Gold results in increased expression of MT1H mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:56,669,814...56,671,129
Ensembl chr16:56,669,814...56,671,129
|
|
G |
MT1L |
metallothionein 1L (pseudogene) |
increases expression |
EXP |
Gold results in increased expression of MT1L mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:56,617,461...56,618,818
Ensembl chr16:56,617,563...56,618,680
|
|
G |
MT1X |
metallothionein 1X |
increases expression |
EXP |
Gold results in increased expression of MT1X mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
increases expression |
EXP |
Gold results in increased expression of MT2A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
MTHFR |
methylenetetrahydrofolate reductase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of MTHFR mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
|
|
G |
MTMR6 |
myotubularin related protein 6 |
decreases expression |
EXP |
Gold results in decreased expression of MTMR6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:25,246,222...25,287,488
Ensembl chr13:25,246,222...25,287,510
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of MTOR protein |
CTD |
PMID:27470402 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
MTSS1 |
MTSS I-BAR domain containing 1 |
increases expression |
EXP |
Gold results in increased expression of MTSS1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 8:124,550,784...124,728,473
Ensembl chr 8:124,550,784...124,728,473
|
|
G |
MTTP |
microsomal triglyceride transfer protein |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of MTTP mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:99,564,130...99,623,997
Ensembl chr 4:99,564,081...99,623,997
|
|
G |
MYCL |
MYCL proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of MYCL mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:39,895,428...39,901,917
Ensembl chr 1:39,895,428...39,902,256
|
|
G |
MYNN |
myoneurin |
decreases expression |
EXP |
Gold results in decreased expression of MYNN mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:169,773,396...169,789,716
Ensembl chr 3:169,773,396...169,789,716
|
|
G |
NAPEPLD |
N-acyl phosphatidylethanolamine phospholipase D |
decreases expression |
EXP |
Gold results in decreased expression of NAPEPLD mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:103,099,776...103,150,001
Ensembl chr 7:103,099,776...103,149,560
|
|
G |
NCEH1 |
neutral cholesterol ester hydrolase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of NCEH1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:172,630,249...172,711,067
Ensembl chr 3:172,630,249...172,711,218
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
increases activity increases expression |
EXP |
Gold results in increased activity of NFE2L2 promoter Gold analog results in increased expression of NFE2L2 mRNA; Gold analog results in increased expression of NFE2L2 protein |
CTD |
PMID:21643505 PMID:36057382 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of NFKB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBID |
NFKB inhibitor delta |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of NFKBID mRNA |
CTD |
PMID:19695318 |
|
NCBI chr19:35,887,952...35,902,303
Ensembl chr19:35,887,630...35,902,303
|
|
G |
NFKBIZ |
NFKB inhibitor zeta |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of NFKBIZ mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:101,827,990...101,861,022
Ensembl chr 3:101,827,991...101,861,022
|
|
G |
NIPBL |
NIPBL cohesin loading factor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of NIPBL mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:36,876,769...37,066,413
Ensembl chr 5:36,876,769...37,066,413
|
|
G |
NOS2 |
nitric oxide synthase 2 |
increases expression |
EXP |
Gold results in increased expression of NOS2 protein |
CTD |
PMID:24022940 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NPLOC4 |
NPL4 homolog, ubiquitin recognition factor |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of NPLOC4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr17:81,556,885...81,637,112
Ensembl chr17:81,556,887...81,648,465
|
|
G |
NPM1 |
nucleophosmin 1 |
decreases expression |
EXP |
Gold results in decreased expression of NPM1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of NQO1 mRNA Gold analog results in increased expression of NQO1 mRNA; Gold results in increased expression of NQO1 mRNA |
CTD |
PMID:28433809 PMID:29705079 PMID:36057382 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
decreases expression |
EXP |
Gold analog results in decreased expression of NR0B2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
|
|
G |
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of NR4A1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507
|
|
G |
NRCAM |
neuronal cell adhesion molecule |
increases expression |
EXP |
Gold results in increased expression of NRCAM mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
|
|
G |
NRIP1 |
nuclear receptor interacting protein 1 |
increases expression |
EXP |
Gold results in increased expression of NRIP1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr21:14,961,235...15,065,936
Ensembl chr21:14,961,235...15,065,936
|
|
G |
NTN4 |
netrin 4 |
increases expression |
EXP |
Gold results in increased expression of NTN4 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr12:95,657,807...95,791,155
Ensembl chr12:95,657,807...95,791,189
|
|
G |
NUCB1 |
nucleobindin 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of NUCB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:48,900,312...48,923,372
Ensembl chr19:48,900,050...48,923,473
|
|
G |
NUDT1 |
nudix hydrolase 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of NUDT1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:2,242,226...2,251,145
Ensembl chr 7:2,242,226...2,251,146
|
|
G |
NUDT12 |
nudix hydrolase 12 |
decreases expression |
EXP |
Gold results in decreased expression of NUDT12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:103,548,855...103,562,789
Ensembl chr 5:103,548,855...103,562,790
|
|
G |
NUDT13 |
nudix hydrolase 13 |
decreases expression |
EXP |
Gold analog results in decreased expression of NUDT13 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:73,110,455...73,131,823
Ensembl chr10:73,110,375...73,131,828
|
|
G |
NUP210 |
nucleoporin 210 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of NUP210 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:13,316,235...13,420,322
Ensembl chr 3:13,316,235...13,420,322
|
|
G |
OBI1 |
ORC ubiquitin ligase 1 |
decreases expression |
EXP |
Gold results in decreased expression of OBI1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:78,614,289...78,659,155
Ensembl chr13:78,614,289...78,659,155
|
|
G |
ODR4 |
odr-4 GPCR localization factor homolog |
decreases expression |
EXP |
Gold results in decreased expression of ODR4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:186,375,838...186,435,031
Ensembl chr 1:186,375,838...186,421,378
|
|
G |
OGDH |
oxoglutarate dehydrogenase |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of OGDH mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:44,606,627...44,709,066
Ensembl chr 7:44,606,572...44,709,066
|
|
G |
OGG1 |
8-oxoguanine DNA glycosylase |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of OGG1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
|
|
G |
ORC4 |
origin recognition complex subunit 4 |
decreases expression |
EXP |
Gold results in decreased expression of ORC4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:147,930,396...148,021,551
Ensembl chr 2:147,930,396...148,021,604
|
|
G |
OS9 |
OS9 endoplasmic reticulum lectin |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of OS9 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr12:57,694,132...57,721,557
Ensembl chr12:57,693,841...57,728,342
|
|
G |
OSGIN1 |
oxidative stress induced growth inhibitor 1 |
increases expression |
EXP |
Gold results in increased expression of OSGIN1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:83,953,240...83,966,332
Ensembl chr16:83,931,311...83,966,332
|
|
G |
P4HB |
prolyl 4-hydroxylase subunit beta |
decreases expression |
ISO |
Gold analog results in decreased expression of P4HB protein |
CTD |
PMID:24780912 |
|
NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions decreases expression |
EXP |
Organogold Compounds promotes the reaction [Gold binds to PARP1 protein] Gold analog results in decreased expression of PARP1 mRNA |
CTD |
PMID:21370912 PMID:36057382 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCBP1 |
poly(rC) binding protein 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of PCBP1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:70,087,477...70,089,203
Ensembl chr 2:70,087,477...70,089,203
|
|
G |
PCCA |
propionyl-CoA carboxylase subunit alpha |
decreases expression |
EXP |
Gold analog results in decreased expression of PCCA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr13:100,089,093...100,530,435
Ensembl chr13:100,089,015...100,530,437
|
|
G |
PCGF5 |
polycomb group ring finger 5 |
decreases expression |
EXP |
Gold results in decreased expression of PCGF5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:91,156,219...91,284,337
Ensembl chr10:91,163,012...91,284,337
|
|
G |
PCGF6 |
polycomb group ring finger 6 |
decreases expression |
EXP |
Gold results in decreased expression of PCGF6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:103,302,796...103,351,140
Ensembl chr10:103,302,796...103,351,144
|
|
G |
PCNA |
proliferating cell nuclear antigen |
decreases expression |
EXP |
Gold analog results in decreased expression of PCNA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PDE4B |
phosphodiesterase 4B |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PDE4B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
|
|
G |
PER3 |
period circadian regulator 3 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of PER3 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:7,784,291...7,845,177
Ensembl chr 1:7,784,291...7,845,177
|
|
G |
PIGA |
phosphatidylinositol glycan anchor biosynthesis class A |
decreases expression |
EXP |
Gold results in decreased expression of PIGA mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:15,319,451...15,335,554
Ensembl chr X:15,319,452...15,335,554
|
|
G |
PIGF |
phosphatidylinositol glycan anchor biosynthesis class F |
decreases expression |
EXP |
Gold results in decreased expression of PIGF mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:46,580,937...46,617,041
Ensembl chr 2:46,580,937...46,617,055
|
|
G |
PIGK |
phosphatidylinositol glycan anchor biosynthesis class K |
decreases expression |
EXP |
Gold results in decreased expression of PIGK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:77,088,989...77,219,430
Ensembl chr 1:77,088,989...77,219,430
|
|
G |
PIGY |
phosphatidylinositol glycan anchor biosynthesis class Y |
decreases expression |
EXP |
Gold results in decreased expression of PIGY mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:88,520,998...88,523,776
Ensembl chr 4:88,520,998...88,523,776
|
|
G |
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PIK3R1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
|
|
G |
PKM |
pyruvate kinase M1/2 |
decreases expression |
ISO |
Gold analog results in decreased expression of PKM protein |
CTD |
PMID:24780912 |
|
NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
|
|
G |
PLA2G6 |
phospholipase A2 group VI |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PLA2G6 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr22:38,111,495...38,181,830
Ensembl chr22:38,111,495...38,214,778
|
|
G |
PLEKHF2 |
pleckstrin homology and FYVE domain containing 2 |
decreases expression |
EXP |
Gold results in decreased expression of PLEKHF2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:95,133,785...95,156,685
Ensembl chr 8:95,115,642...95,156,698
|
|
G |
PLIN3 |
perilipin 3 |
increases expression |
ISO |
Gold analog results in increased expression of PLIN3 protein |
CTD |
PMID:24780912 |
|
NCBI chr19:4,838,341...4,867,667
Ensembl chr19:4,838,341...4,867,694
|
|
G |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PMAIP1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
|
|
G |
PNLIPRP3 |
pancreatic lipase related protein 3 |
increases expression |
EXP |
Gold results in increased expression of PNLIPRP3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr10:116,427,847...116,477,957
Ensembl chr10:116,427,847...116,477,957
|
|
G |
POLK |
DNA polymerase kappa |
decreases expression |
EXP |
Gold results in decreased expression of POLK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:75,510,774...75,609,991
Ensembl chr 5:75,511,845...75,609,991
|
|
G |
POLR2K |
RNA polymerase II, I and III subunit K |
decreases expression |
EXP |
Gold results in decreased expression of POLR2K mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:100,150,636...100,154,003
Ensembl chr 8:100,150,623...100,154,003
|
|
G |
POPDC1 |
popeye domain cAMP effector 1 |
increases expression |
EXP |
Gold results in increased expression of POPDC1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 6:105,096,822...105,137,157
Ensembl chr 6:105,096,822...105,137,157
|
|
G |
POPDC3 |
popeye domain cAMP effector 3 |
increases expression |
EXP |
Gold results in increased expression of POPDC3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 6:105,157,900...105,180,014
Ensembl chr 6:105,157,900...105,180,014
|
|
G |
POR |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of POR mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
|
|
G |
PPP1CB |
protein phosphatase 1 catalytic subunit beta |
decreases expression |
EXP |
Gold results in decreased expression of PPP1CB mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:28,751,604...28,802,940
Ensembl chr 2:28,751,640...28,802,940
|
|
G |
PPP2R1A |
protein phosphatase 2 scaffold subunit Aalpha |
decreases expression |
ISO |
Gold analog results in decreased expression of PPP2R1A protein |
CTD |
PMID:24780912 |
|
NCBI chr19:52,190,052...52,229,518
Ensembl chr19:52,170,936...52,229,518
|
|
G |
PPP2R5E |
protein phosphatase 2 regulatory subunit B'epsilon |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of PPP2R5E mRNA |
CTD |
PMID:19695318 |
|
NCBI chr14:63,371,364...63,543,377
Ensembl chr14:63,371,364...63,543,377
|
|
G |
PRDX1 |
peroxiredoxin 1 |
decreases expression increases expression |
ISO EXP |
Gold analog results in decreased expression of PRDX1 protein Gold analog results in increased expression of PRDX1 mRNA |
CTD |
PMID:24780912 PMID:36057382 |
|
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
|
|
G |
PRRC2A |
proline rich coiled-coil 2A |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PRRC2A mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:31,620,715...31,637,771
Ensembl chr 6:31,620,715...31,637,771
|
|
G |
PSAT1 |
phosphoserine aminotransferase 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of PSAT1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
|
|
G |
PSMD14 |
proteasome 26S subunit, non-ATPase 14 |
decreases expression |
EXP |
Gold results in decreased expression of PSMD14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:161,308,425...161,411,717
Ensembl chr 2:161,308,425...161,411,717
|
|
G |
PTBP2 |
polypyrimidine tract binding protein 2 |
decreases expression |
EXP |
Gold results in decreased expression of PTBP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:96,721,784...96,823,739
Ensembl chr 1:96,721,665...96,823,738
|
|
G |
PTGR1 |
prostaglandin reductase 1 |
increases expression |
EXP |
Gold results in increased expression of PTGR1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
|
|
G |
PTGR2 |
prostaglandin reductase 2 |
decreases expression |
EXP |
Gold results in decreased expression of PTGR2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:73,851,831...73,885,726
Ensembl chr14:73,851,831...73,885,726
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO EXP |
[Gold co-treated with Silicon Dioxide] results in increased expression of PTGS2 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of PTGS2 mRNA Gold results in increased expression of PTGS2 mRNA |
CTD |
PMID:22155353 PMID:28433809 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTPRC |
protein tyrosine phosphatase receptor type C |
increases expression |
EXP |
Gold analog results in increased expression of PTPRC mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:198,638,713...198,757,476
Ensembl chr 1:198,638,457...198,759,342
|
|
G |
PTS |
6-pyruvoyltetrahydropterin synthase |
decreases expression |
EXP |
Gold results in decreased expression of PTS mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:112,226,428...112,233,973
Ensembl chr11:112,226,367...112,269,955
|
|
G |
PVR |
PVR cell adhesion molecule |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of PVR mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:44,643,910...44,666,162
Ensembl chr19:44,643,798...44,666,162
|
|
G |
RAB11A |
RAB11A, member RAS oncogene family |
decreases expression |
EXP |
Gold results in decreased expression of RAB11A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:65,869,491...65,891,989
Ensembl chr15:65,726,054...65,891,989
|
|
G |
RAB18 |
RAB18, member RAS oncogene family |
decreases expression |
EXP |
Gold results in decreased expression of RAB18 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:27,504,304...27,542,239
Ensembl chr10:27,504,174...27,545,117
|
|
G |
RABGGTB |
Rab geranylgeranyltransferase subunit beta |
decreases expression |
EXP |
Gold results in decreased expression of RABGGTB mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:75,786,194...75,795,090
Ensembl chr 1:75,786,197...75,795,086
|
|
G |
RAD51 |
RAD51 recombinase |
decreases expression |
EXP |
Gold analog results in decreased expression of RAD51 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr15:40,694,733...40,732,340
Ensembl chr15:40,694,774...40,732,340
|
|
G |
RAD51B |
RAD51 paralog B |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of RAD51B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr14:67,819,779...68,683,096
Ensembl chr14:67,819,779...68,730,218
|
|
G |
RAI14 |
retinoic acid induced 14 |
increases expression |
EXP |
Gold results in increased expression of RAI14 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:34,656,328...34,832,612
Ensembl chr 5:34,656,328...34,832,612
|
|
G |
RB1CC1 |
RB1 inducible coiled-coil 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of RB1CC1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 8:52,622,458...52,714,435
Ensembl chr 8:52,622,458...52,745,843
|
|
G |
RBM12 |
RNA binding motif protein 12 |
decreases expression |
EXP |
Gold results in decreased expression of RBM12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr20:35,648,925...35,664,900
Ensembl chr20:35,648,925...35,664,956
|
|
G |
RBP1 |
retinol binding protein 1 |
increases expression |
EXP |
Gold results in increased expression of RBP1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 3:139,517,438...139,539,742
Ensembl chr 3:139,517,434...139,539,829
|
|
G |
RC3H1 |
ring finger and CCCH-type domains 1 |
decreases expression |
EXP |
Gold results in decreased expression of RC3H1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:173,931,084...174,022,357
Ensembl chr 1:173,931,084...174,022,357
|
|
G |
RDX |
radixin |
decreases expression |
EXP |
Gold analog results in decreased expression of RDX mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:110,174,922...110,296,614
Ensembl chr11:109,864,295...110,296,712
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein] |
CTD |
PMID:27634460 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RFK |
riboflavin kinase |
decreases expression |
EXP |
Gold results in decreased expression of RFK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:76,385,526...76,394,426
Ensembl chr 9:76,385,526...76,394,517
|
|
G |
RHOU |
ras homolog family member U |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of RHOU mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:228,644,647...228,746,669
Ensembl chr 1:228,735,479...228,746,664
|
|
G |
RNF11 |
ring finger protein 11 |
decreases expression |
EXP |
Gold results in decreased expression of RNF11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:51,236,273...51,273,447
Ensembl chr 1:51,236,273...51,273,447
|
|
G |
RNF13 |
ring finger protein 13 |
decreases expression |
EXP |
Gold results in decreased expression of RNF13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:149,812,688...149,962,139
Ensembl chr 3:149,812,770...149,962,139
|
|
G |
RNF138 |
ring finger protein 138 |
decreases expression |
EXP |
Gold results in decreased expression of RNF138 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:32,091,874...32,131,561
Ensembl chr18:32,091,874...32,131,561
|
|
G |
RNF149 |
ring finger protein 149 |
decreases expression |
EXP |
Gold results in decreased expression of RNF149 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:101,271,219...101,308,701
Ensembl chr 2:101,271,219...101,308,701
|
|
G |
RNF2 |
ring finger protein 2 |
decreases expression |
EXP |
Gold results in decreased expression of RNF2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:185,045,558...185,102,603
Ensembl chr 1:185,045,497...185,102,603
|
|
G |
RNFT1 |
ring finger protein, transmembrane 1 |
decreases expression |
EXP |
Gold results in decreased expression of RNFT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:59,952,240...59,964,740
Ensembl chr17:59,952,240...59,964,761
|
|
G |
RO60 |
Ro60, Y RNA binding protein |
decreases expression |
EXP |
Gold results in decreased expression of RO60 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:193,059,612...193,091,777
Ensembl chr 1:193,059,454...193,091,777
|
|
G |
RP2 |
RP2 activator of ARL3 GTPase |
decreases expression |
EXP |
Gold results in decreased expression of RP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:46,837,043...46,882,358
Ensembl chr X:46,837,043...46,882,358
|
|
G |
RPS27L |
ribosomal protein S27 like |
decreases expression |
EXP |
Gold results in decreased expression of RPS27L mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in decreased expression of RPS6KB1 protein |
CTD |
PMID:27470402 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
RTN4 |
reticulon 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of RTN4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:54,972,189...55,137,831
Ensembl chr 2:54,972,187...55,112,621
|
|
G |
SAA1 |
serum amyloid A1 |
increases expression multiple interactions |
EXP |
Gold results in increased expression of SAA1 mRNA Gold promotes the reaction [SAA1 protein binds to TLR2 protein] |
CTD |
PMID:29705079 |
|
NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977
|
|
G |
SAR1B |
secretion associated Ras related GTPase 1B |
decreases expression |
EXP |
Gold results in decreased expression of SAR1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:134,601,149...134,632,828
Ensembl chr 5:134,601,149...134,649,271
|
|
G |
SARNP |
SAP domain containing ribonucleoprotein |
decreases expression |
EXP |
Gold results in decreased expression of SARNP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:55,752,463...55,817,724
Ensembl chr12:55,752,463...55,817,724
|
|
G |
SCOC |
short coiled-coil protein |
decreases expression |
EXP |
Gold results in decreased expression of SCOC mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:140,257,308...140,385,728
Ensembl chr 4:140,257,286...140,385,728
|
|
G |
SCP2 |
sterol carrier protein 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of SCP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:52,927,276...53,051,698
Ensembl chr 1:52,927,276...53,051,698
|
|
G |
SEC23A |
SEC23 homolog A, COPII coat complex component |
decreases expression |
EXP |
Gold results in decreased expression of SEC23A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:39,031,919...39,103,235
Ensembl chr14:39,031,919...39,109,646
|
|
G |
SEC24A |
SEC24 homolog A, COPII coat complex component |
decreases expression |
EXP |
Gold results in decreased expression of SEC24A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:134,648,382...134,727,909
Ensembl chr 5:134,648,785...134,727,909
|
|
G |
SEL1L3 |
SEL1L family member 3 |
increases expression |
EXP |
Gold results in increased expression of SEL1L3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 4:25,713,964...25,863,566
Ensembl chr 4:25,747,433...25,863,760
|
|
G |
SELENOT |
selenoprotein T |
decreases expression |
EXP |
Gold results in decreased expression of SELENOT mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:150,603,321...150,630,436
Ensembl chr 3:150,602,875...150,630,436
|
|
G |
SEPTIN8 |
septin 8 |
decreases expression |
ISO |
Gold analog results in decreased expression of SEPTIN8 protein |
CTD |
PMID:24780912 |
|
NCBI chr 5:132,750,819...132,780,083
Ensembl chr 5:132,750,819...132,807,241
|
|
G |
SERP1 |
stress associated endoplasmic reticulum protein 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of SERP1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:150,541,998...150,546,496
Ensembl chr 3:150,541,998...150,603,228
|
|
G |
SERPINE1 |
serpin family E member 1 |
increases expression |
EXP |
Gold results in increased expression of SERPINE1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SERPINH1 |
serpin family H member 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of SERPINH1 protein |
CTD |
PMID:24780912 |
|
NCBI chr11:75,562,253...75,572,783
Ensembl chr11:75,562,056...75,572,783
|
|
G |
SH3KBP1 |
SH3 domain containing kinase binding protein 1 |
increases expression |
EXP |
Gold results in increased expression of SH3KBP1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr X:19,533,977...19,887,600
Ensembl chr X:19,533,977...19,887,600
|
|
G |
SLC25A24 |
solute carrier family 25 member 24 |
decreases expression |
ISO |
Gold analog results in decreased expression of SLC25A24 protein |
CTD |
PMID:24780912 |
|
NCBI chr 1:108,134,043...108,200,343
Ensembl chr 1:108,134,043...108,200,849
|
|
G |
SLIRP |
SRA stem-loop interacting RNA binding protein |
decreases expression |
EXP |
Gold results in decreased expression of SLIRP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:77,708,071...77,717,598
Ensembl chr14:77,708,071...77,761,104
|
|
G |
SMARCAD1 |
SNF2 related chromatin remodeling ATPase with DExD box 1 |
decreases expression |
EXP |
Gold results in decreased expression of SMARCAD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:94,207,608...94,291,292
Ensembl chr 4:94,207,611...94,291,292
|
|
G |
SMC4 |
structural maintenance of chromosomes 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of SMC4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:160,399,650...160,434,953
Ensembl chr 3:160,399,274...160,434,954
|
|
G |
SMC6 |
structural maintenance of chromosomes 6 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of SMC6 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:17,663,812...17,753,810
Ensembl chr 2:17,663,812...17,800,242
|
|
G |
SNRPB2 |
small nuclear ribonucleoprotein polypeptide B2 |
decreases expression |
EXP |
Gold results in decreased expression of SNRPB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr20:16,730,026...16,742,564
Ensembl chr20:16,729,961...16,742,564
|
|
G |
SNX6 |
sorting nexin 6 |
decreases expression |
EXP |
Gold results in decreased expression of SNX6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:34,561,093...34,630,148
Ensembl chr14:34,561,093...34,630,160
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of SOD1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SP100 |
SP100 nuclear antigen |
decreases expression |
EXP |
Gold results in decreased expression of SP100 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:230,416,201...230,545,606
Ensembl chr 2:230,415,942...230,545,606
|
|
G |
SP3 |
Sp3 transcription factor |
decreases expression |
EXP |
Gold results in decreased expression of SP3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:173,900,775...173,965,702
Ensembl chr 2:173,880,850...173,965,373
|
|
G |
SPAST |
spastin |
decreases expression |
EXP |
Gold results in decreased expression of SPAST mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:32,063,556...32,157,637
Ensembl chr 2:32,063,556...32,157,637
|
|
G |
SPATA2 |
spermatogenesis associated 2 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of SPATA2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr20:49,903,391...49,915,529
Ensembl chr20:49,903,391...49,915,529
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of SREBF1 mRNA Gold analog results in decreased expression of SREBF1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
|
|
G |
SREK1IP1 |
SREK1 interacting protein 1 |
decreases expression |
EXP |
Gold results in decreased expression of SREK1IP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:64,718,148...64,768,691
Ensembl chr 5:64,718,148...64,768,691
|
|
G |
SRP9 |
signal recognition particle 9 |
decreases expression |
EXP |
Gold results in decreased expression of SRP9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:225,777,826...225,790,464
Ensembl chr 1:225,777,813...225,790,468
|
|
G |
SRSF10 |
serine and arginine rich splicing factor 10 |
decreases expression |
EXP |
Gold results in decreased expression of SRSF10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:23,964,347...23,980,327
Ensembl chr 1:23,964,347...23,980,927
|
|
G |
SRSF3 |
serine and arginine rich splicing factor 3 |
decreases expression |
EXP |
Gold results in decreased expression of SRSF3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:36,594,362...36,605,600
Ensembl chr 6:36,594,353...36,605,911
|
|
G |
SRSF7 |
serine and arginine rich splicing factor 7 |
decreases expression |
EXP |
Gold results in decreased expression of SRSF7 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:38,743,599...38,751,494
Ensembl chr 2:38,743,599...38,751,494
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
multiple interactions increases expression |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased expression of STAT1 mRNA Gold results in increased expression of STAT1 mRNA |
CTD |
PMID:22155353 |
|
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
increases expression multiple interactions |
ISO |
Gold results in increased expression of STAT3 mRNA [Gold co-treated with Silicon Dioxide] results in increased expression of STAT3 mRNA |
CTD |
PMID:22155353 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
STAU2 |
staufen double-stranded RNA binding protein 2 |
decreases expression |
EXP |
Gold results in decreased expression of STAU2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:73,420,369...73,747,480
Ensembl chr 8:73,420,369...73,747,708
|
|
G |
STBD1 |
starch binding domain 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of STBD1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:76,306,733...76,311,130
Ensembl chr 4:76,306,733...76,311,130
|
|
G |
STEAP1 |
STEAP family member 1 |
decreases expression |
EXP |
Gold results in decreased expression of STEAP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:90,154,469...90,164,827
Ensembl chr 7:90,154,456...90,164,829
|
|
G |
STK26 |
serine/threonine kinase 26 |
decreases expression |
EXP |
Gold results in decreased expression of STK26 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:132,023,302...132,075,943
Ensembl chr X:132,023,302...132,075,943
|
|
G |
SUCLA2 |
succinate-CoA ligase ADP-forming subunit beta |
decreases expression |
EXP |
Gold analog results in decreased expression of SUCLA2 mRNA; Gold results in decreased expression of SUCLA2 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr13:47,942,656...48,001,273
Ensembl chr13:47,745,736...48,037,968
|
|
G |
SYT1 |
synaptotagmin 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of SYT1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr12:78,863,982...79,452,008
Ensembl chr12:78,863,993...79,452,008
|
|
G |
SYVN1 |
synoviolin 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of SYVN1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:65,127,279...65,134,519
Ensembl chr11:65,121,780...65,134,532
|
|
G |
TACSTD2 |
tumor associated calcium signal transducer 2 |
increases expression |
EXP |
Gold results in increased expression of TACSTD2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 1:58,575,433...58,577,252
Ensembl chr 1:58,575,433...58,577,252
|
|
G |
TADA1 |
transcriptional adaptor 1 |
decreases expression |
EXP |
Gold results in decreased expression of TADA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:166,856,510...166,876,264
Ensembl chr 1:166,856,510...166,876,264
|
|
G |
TAF9B |
TATA-box binding protein associated factor 9b |
decreases expression |
EXP |
Gold results in decreased expression of TAF9B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:78,129,748...78,139,650
Ensembl chr X:78,129,748...78,139,650
|
|
G |
TAGLN |
transgelin |
decreases expression |
EXP |
Gold analog results in decreased expression of TAGLN mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
|
|
G |
TBL1XR1 |
TBL1X/Y related 1 |
decreases expression |
EXP |
Gold results in decreased expression of TBL1XR1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:177,019,344...177,201,800
Ensembl chr 3:177,019,340...177,228,000
|
|
G |
TCEA1 |
transcription elongation factor A1 |
decreases expression |
EXP |
Gold results in decreased expression of TCEA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:53,966,556...54,022,448
Ensembl chr 8:53,966,552...54,022,448
|
|
G |
TDO2 |
tryptophan 2,3-dioxygenase |
decreases expression |
EXP |
Gold results in decreased expression of TDO2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:155,903,696...155,920,406
Ensembl chr 4:155,854,738...155,920,406
|
|
G |
TEX30 |
testis expressed 30 |
decreases expression |
EXP |
Gold results in decreased expression of TEX30 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:102,765,888...102,773,786
Ensembl chr13:102,765,888...102,773,811
|
|
G |
TFEC |
transcription factor EC |
decreases expression |
EXP |
Gold results in decreased expression of TFEC mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:115,935,152...116,159,896
Ensembl chr 7:115,935,148...116,159,896
|
|
G |
TFPI2 |
tissue factor pathway inhibitor 2 |
increases expression |
EXP |
Gold results in increased expression of TFPI2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of TGFB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
THAP1 |
THAP domain containing 1 |
decreases expression |
EXP |
Gold results in decreased expression of THAP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:42,836,674...42,843,325
Ensembl chr 8:42,836,674...42,843,325
|
|
G |
TIA1 |
TIA1 cytotoxic granule associated RNA binding protein |
decreases expression |
EXP |
Gold results in decreased expression of TIA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:70,209,444...70,248,793
Ensembl chr 2:70,209,444...70,248,660
|
|
G |
TKT |
transketolase |
decreases expression |
ISO |
Gold analog results in decreased expression of TKT protein |
CTD |
PMID:24780912 |
|
NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
|
|
G |
TLK1 |
tousled like kinase 1 |
increases expression |
EXP |
Gold results in increased expression of TLK1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:170,990,823...171,231,293
Ensembl chr 2:170,990,823...171,231,314
|
|
G |
TLR2 |
toll like receptor 2 |
multiple interactions increases expression |
EXP |
Gold promotes the reaction [SAA1 protein binds to TLR2 protein] Gold results in increased expression of TLR2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TM4SF1 |
transmembrane 4 L six family member 1 |
increases expression |
EXP |
Gold results in increased expression of TM4SF1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 3:149,369,022...149,377,649
Ensembl chr 3:149,369,022...149,377,692
|
|
G |
TMED10 |
transmembrane p24 trafficking protein 10 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of TMED10 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr14:75,131,469...75,176,612
Ensembl chr14:75,131,469...75,176,612
|
|
G |
TNF |
tumor necrosis factor |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of TNF protein [Gold co-treated with Silicon Dioxide] results in increased secretion of TNF protein |
CTD |
PMID:22155353 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFAIP3 |
TNF alpha induced protein 3 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
|
|
G |
TNFAIP8L1 |
TNF alpha induced protein 8 like 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of TNFAIP8L1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:4,639,516...4,655,568
Ensembl chr19:4,639,516...4,655,568
|
|
G |
TNFRSF10A |
TNF receptor superfamily member 10a |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of TNFRSF10A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of TNFRSF1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
decreases expression |
EXP |
Gold analog results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
|
|
G |
TP53 |
tumor protein p53 |
increases expression |
ISO |
Gold analog results in increased expression of TRP53 mRNA |
CTD |
PMID:22486372 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TPT1 |
tumor protein, translationally-controlled 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of TPT1 protein |
CTD |
PMID:24780912 |
|
NCBI chr13:45,333,471...45,341,183
Ensembl chr13:45,333,471...45,341,284
|
|
G |
TRIM23 |
tripartite motif containing 23 |
decreases expression |
EXP |
Gold results in decreased expression of TRIM23 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:65,589,690...65,624,333
Ensembl chr 5:65,589,690...65,625,975
|
|
G |
TRMT13 |
tRNA methyltransferase 13 homolog |
decreases expression |
EXP |
Gold results in decreased expression of TRMT13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:100,133,163...100,150,496
Ensembl chr 1:100,133,150...100,150,496
|
|
G |
TRUB1 |
TruB pseudouridine synthase family member 1 |
decreases expression |
EXP |
Gold results in decreased expression of TRUB1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:114,938,195...114,977,676
Ensembl chr10:114,938,195...114,977,676
|
|
G |
TUBA1A |
tubulin alpha 1a |
decreases expression |
ISO |
Gold analog results in decreased expression of TUBA1A protein |
CTD |
PMID:24780912 |
|
NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,324
|
|
G |
TUBB |
tubulin beta class I |
decreases expression |
ISO |
Gold analog results in decreased expression of TUBB5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 6:30,720,352...30,725,422
Ensembl chr 6:30,717,435...30,725,538
|
|
G |
TUFM |
Tu translation elongation factor, mitochondrial |
multiple interactions |
ISO |
Gold analog results in decreased expression of and results in increased phosphorylation of TUFM protein |
CTD |
PMID:24780912 |
|
NCBI chr16:28,842,411...28,846,348
Ensembl chr16:28,842,411...28,846,348
|
|
G |
TXNDC5 |
thioredoxin domain containing 5 |
multiple interactions |
ISO |
Gold analog results in decreased expression of and results in increased phosphorylation of TXNDC5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 6:7,881,517...7,910,788
Ensembl chr 6:7,881,517...7,910,788
|
|
G |
TXNIP |
thioredoxin interacting protein |
decreases expression |
EXP |
Gold analog results in decreased expression of TXNIP mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
decreases activity increases expression |
ISO EXP |
Gold results in decreased activity of TXNRD1 protein Gold results in increased expression of TXNRD1 mRNA |
CTD |
PMID:16510263 PMID:20851179 PMID:29705079 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
TXNRD2 |
thioredoxin reductase 2 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of TXNRD2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
|
|
G |
UAP1L1 |
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of UAP1L1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 9:137,077,517...137,084,538
Ensembl chr 9:137,077,517...137,084,539
|
|
G |
UBA2 |
ubiquitin like modifier activating enzyme 2 |
decreases expression |
EXP |
Gold results in decreased expression of UBA2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:34,428,381...34,471,251
Ensembl chr19:34,428,352...34,471,251
|
|
G |
UBE2G2 |
ubiquitin conjugating enzyme E2 G2 |
decreases expression |
EXP |
Gold analog results in decreased expression of UBE2G2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr21:44,768,580...44,801,820
Ensembl chr21:44,768,580...44,801,826
|
|
G |
UBE2H |
ubiquitin conjugating enzyme E2 H |
increases expression |
EXP |
Gold results in increased expression of UBE2H mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:129,830,732...129,952,960
Ensembl chr 7:129,830,732...129,952,960
|
|
G |
UBE2N |
ubiquitin conjugating enzyme E2 N |
decreases expression |
EXP |
Gold results in decreased expression of UBE2N mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:93,405,684...93,441,947
Ensembl chr12:93,405,673...93,441,947
|
|
G |
UBE2W |
ubiquitin conjugating enzyme E2 W |
decreases expression |
EXP |
Gold results in decreased expression of UBE2W mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:73,780,096...73,878,862
Ensembl chr 8:73,780,097...73,878,910
|
|
G |
UCP2 |
uncoupling protein 2 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of UCP2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,061...73,982,843
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
decreases expression |
EXP |
Gold analog results in decreased expression of UGT1A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT2A1 |
UDP glucuronosyltransferase family 2 member A1 complex locus |
decreases expression |
EXP |
Gold analog results in decreased expression of UGT2A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:69,588,417...69,653,247
Ensembl chr 4:69,588,417...69,653,249
|
|
G |
UIMC1 |
ubiquitin interaction motif containing 1 |
decreases expression increases expression |
EXP |
Gold results in decreased expression of UIMC1 mRNA Gold results in increased expression of UIMC1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:176,905,005...177,022,602
Ensembl chr 5:176,905,005...177,022,633
|
|
G |
UPP2 |
uridine phosphorylase 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of UPP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:157,995,179...158,136,154
Ensembl chr 2:157,876,679...158,136,154
|
|
G |
USP1 |
ubiquitin specific peptidase 1 |
decreases expression |
EXP |
Gold results in decreased expression of USP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:62,436,395...62,451,804
Ensembl chr 1:62,436,297...62,451,804
|
|
G |
USP15 |
ubiquitin specific peptidase 15 |
decreases expression |
EXP |
Gold results in decreased expression of USP15 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:62,260,404...62,416,389
Ensembl chr12:62,260,338...62,417,431
|
|
G |
USP16 |
ubiquitin specific peptidase 16 |
decreases expression |
EXP |
Gold results in decreased expression of USP16 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr21:29,024,668...29,054,488
Ensembl chr21:29,024,629...29,054,488
|
|
G |
USP33 |
ubiquitin specific peptidase 33 |
decreases expression |
EXP |
Gold results in decreased expression of USP33 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:77,695,987...77,759,852
Ensembl chr 1:77,695,987...77,759,852
|
|
G |
USP5 |
ubiquitin specific peptidase 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of USP5 protein |
CTD |
PMID:24780912 |
|
NCBI chr12:6,852,150...6,866,632
Ensembl chr12:6,852,148...6,866,632
|
|
G |
VCL |
vinculin |
decreases expression |
ISO |
Gold analog results in decreased expression of VCL protein |
CTD |
PMID:24780912 |
|
NCBI chr10:73,998,116...74,121,363
Ensembl chr10:73,995,193...74,121,363
|
|
G |
VIM |
vimentin |
increases degradation |
EXP |
Gold analog results in increased degradation of VIM protein |
CTD |
PMID:26551149 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
WBP4 |
WW domain binding protein 4 |
decreases expression |
EXP |
Gold results in decreased expression of WBP4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:41,061,509...41,084,006
Ensembl chr13:41,061,509...41,084,006
|
|
G |
WEE1 |
WEE1 G2 checkpoint kinase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of WEE1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:9,573,670...9,589,985
Ensembl chr11:9,573,670...9,593,457
|
|
G |
XPA |
XPA, DNA damage recognition and repair factor |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of XPA mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:97,654,398...97,697,340
Ensembl chr 9:97,674,909...97,697,340
|
|
G |
XPC |
XPC complex subunit, DNA damage recognition and repair factor |
decreases expression |
EXP |
Gold analog results in decreased expression of XPC mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:14,145,147...14,178,601
Ensembl chr 3:14,145,145...14,178,621
|
|
G |
XRCC5 |
X-ray repair cross complementing 5 |
decreases expression |
EXP |
Gold analog results in decreased expression of XRCC5 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:216,109,348...216,206,293
Ensembl chr 2:216,107,464...216,206,303
|
|
G |
YOD1 |
YOD1 deubiquitinase |
decreases expression |
EXP |
Gold results in decreased expression of YOD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:207,043,849...207,053,116
Ensembl chr 1:207,043,849...207,052,980
|
|
G |
YWHAG |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of YWHAG mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:76,326,799...76,358,991
Ensembl chr 7:76,326,799...76,358,991
|
|
G |
ZBTB21 |
zinc finger and BTB domain containing 21 |
decreases expression |
EXP |
Gold results in decreased expression of ZBTB21 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr21:41,986,831...42,010,360
Ensembl chr21:41,986,831...42,010,387
|
|
G |
ZBTB41 |
zinc finger and BTB domain containing 41 |
decreases expression |
EXP |
Gold results in decreased expression of ZBTB41 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:197,153,682...197,201,293
Ensembl chr 1:197,153,682...197,201,293
|
|
G |
ZC3H15 |
zinc finger CCCH-type containing 15 |
decreases expression |
EXP |
Gold results in decreased expression of ZC3H15 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:186,486,260...186,509,361
Ensembl chr 2:186,486,253...186,511,929
|
|
G |
ZCCHC10 |
zinc finger CCHC-type containing 10 |
decreases expression |
EXP |
Gold results in decreased expression of ZCCHC10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:132,996,985...133,026,549
Ensembl chr 5:132,996,985...133,026,604
|
|
G |
ZCCHC9 |
zinc finger CCHC-type containing 9 |
decreases expression |
EXP |
Gold results in decreased expression of ZCCHC9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:81,301,587...81,313,297
Ensembl chr 5:81,301,587...81,313,297
|
|
G |
ZCRB1 |
zinc finger CCHC-type and RNA binding motif containing 1 |
decreases expression |
EXP |
Gold results in decreased expression of ZCRB1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:42,312,086...42,326,094
Ensembl chr12:42,312,086...42,326,257
|
|
G |
ZDHHC17 |
zinc finger DHHC-type palmitoyltransferase 17 |
decreases expression |
EXP |
Gold results in decreased expression of ZDHHC17 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:76,764,115...76,853,701
Ensembl chr12:76,764,103...76,853,696
|
|
G |
ZDHHC20 |
zinc finger DHHC-type palmitoyltransferase 20 |
decreases expression |
EXP |
Gold results in decreased expression of ZDHHC20 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:21,372,571...21,459,303
Ensembl chr13:21,348,784...21,459,370
|
|
G |
ZFAND1 |
zinc finger AN1-type containing 1 |
decreases expression |
EXP |
Gold results in decreased expression of ZFAND1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:81,701,331...81,721,304
Ensembl chr 8:81,701,334...81,732,903
|
|
G |
ZFAND6 |
zinc finger AN1-type containing 6 |
decreases expression |
EXP |
Gold results in decreased expression of ZFAND6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:80,058,951...80,138,393
Ensembl chr15:80,059,568...80,140,292
|
|
G |
ZFYVE16 |
zinc finger FYVE-type containing 16 |
decreases expression |
EXP |
Gold results in decreased expression of ZFYVE16 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:80,407,610...80,483,379
Ensembl chr 5:80,408,013...80,483,379
|
|
G |
ZMPSTE24 |
zinc metallopeptidase STE24 |
decreases expression |
EXP |
Gold results in decreased expression of ZMPSTE24 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:40,258,236...40,294,180
Ensembl chr 1:40,258,041...40,294,180
|
|
G |
ZNF124 |
zinc finger protein 124 |
decreases expression |
EXP |
Gold results in decreased expression of ZNF124 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:247,121,975...247,172,379
Ensembl chr 1:247,121,975...247,172,020
|
|
G |
ZNF22 |
zinc finger protein 22 |
decreases expression |
EXP |
Gold results in decreased expression of ZNF22 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:45,000,923...45,005,326
Ensembl chr10:45,000,923...45,005,326
|
|
G |
ZNF273 |
zinc finger protein 273 |
decreases expression |
EXP |
Gold results in decreased expression of ZNF273 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:64,877,603...64,937,316
Ensembl chr 7:64,870,172...64,930,981
|
|
G |
ZNF277 |
zinc finger protein 277 |
decreases expression |
EXP |
Gold results in decreased expression of ZNF277 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:112,206,695...112,343,934
Ensembl chr 7:112,206,695...112,343,934
|
|
G |
ZNF322P1 |
zinc finger protein 322 pseudogene 1 |
decreases expression |
EXP |
Gold results in decreased expression of ZNF322P1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:97,195,351...97,200,145
Ensembl chr 9:97,198,303...97,199,511
|
|
G |
ZNF492 |
zinc finger protein 492 |
decreases expression |
EXP |
Gold results in decreased expression of ZNF492 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:22,634,324...22,667,671
Ensembl chr19:22,634,324...22,667,671
|
|
G |
ZNF572 |
zinc finger protein 572 |
decreases expression |
EXP |
Gold results in decreased expression of ZNF572 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:124,973,295...124,979,389
Ensembl chr 8:124,973,295...124,979,389
|
|
G |
ZNF721 |
zinc finger protein 721 |
decreases expression |
EXP |
Gold results in decreased expression of ZNF721 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:439,988...499,156
Ensembl chr 4:425,815...499,156
|
|
G |
ZNF92 |
zinc finger protein 92 |
decreases expression |
EXP |
Gold results in decreased expression of ZNF92 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:65,373,855...65,401,136
Ensembl chr 7:65,373,799...65,401,136
|
|
G |
ZRANB2 |
zinc finger RANBP2-type containing 2 |
decreases expression |
EXP |
Gold results in decreased expression of ZRANB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:71,063,291...71,081,035
Ensembl chr 1:71,063,291...71,081,289
|
|
G |
ZUP1 |
zinc finger containing ubiquitin peptidase 1 |
decreases expression |
EXP |
Gold results in decreased expression of ZUP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:116,635,618...116,668,766
Ensembl chr 6:116,635,618...116,668,794
|
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:36343453 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
ALB |
albumin |
affects binding |
EXP |
Auranofin analog binds to ALB protein |
CTD |
PMID:16791640 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
BAK1 |
BCL2 antagonist/killer 1 |
multiple interactions increases response to substance |
ISO |
[BAX co-treated with BAK1] results in increased susceptibility to Auranofin; BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAK1 results in increased susceptibility to Auranofin |
CTD |
PMID:18789312 PMID:21172426 |
|
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions increases response to substance |
ISO |
[BAX co-treated with BAK1] results in increased susceptibility to Auranofin; BAX mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAX results in increased susceptibility to Auranofin |
CTD |
PMID:18789312 PMID:21172426 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP |
BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] |
CTD |
PMID:18789312 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity |
EXP ISO |
Auranofin promotes the reaction [TNF protein results in increased activity of CASP3 protein]; Auranofin results in decreased expression of and results in increased cleavage of CASP3 protein; BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein]; BAX mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] |
CTD |
PMID:15159275 PMID:15191400 PMID:18789312 PMID:20542334 PMID:21699084 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
multiple interactions |
EXP |
Auranofin results in decreased expression of and results in increased cleavage of CASP8 protein |
CTD |
PMID:20542334 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
Auranofin results in decreased expression of and results in increased cleavage of CASP9 protein |
CTD |
PMID:20542334 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression |
EXP |
Auranofin results in increased expression of CDKN1A protein |
CTD |
PMID:20542334 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CEBPE |
CCAAT enhancer binding protein epsilon |
multiple interactions |
EXP |
[Auranofin co-treated with Tretinoin] results in increased expression of CEBPE protein |
CTD |
PMID:15159275 |
|
NCBI chr14:23,117,306...23,119,255
Ensembl chr14:23,117,036...23,120,256
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO EXP |
Auranofin inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CHUK protein]; Auranofin inhibits the reaction [Lipopolysaccharides results in increased activity of CHUK protein] Auranofin inhibits the reaction [TNF protein results in increased activity of CHUK protein] |
CTD |
PMID:10820281 |
|
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
G |
DIO1 |
iodothyronine deiodinase 1 |
decreases activity |
EXP |
Auranofin results in decreased activity of DIO1 protein |
CTD |
PMID:34662569 |
|
NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
Auranofin promotes the reaction [arsenite results in increased expression of and results in increased secretion of EGF protein] |
CTD |
PMID:36343453 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
EXP |
[Peptidoglycan co-treated with Lipopolysaccharides] promotes the reaction [Auranofin results in increased expression of GPX1 protein]; Auranofin promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of GPX1 protein] |
CTD |
PMID:21355852 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
EXP |
Auranofin promotes the reaction [arsenite results in increased activity of GSR protein] |
CTD |
PMID:36343453 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
increases response to substance |
EXP |
HLA-DQA1 gene polymorphism results in increased susceptibility to Auranofin |
CTD |
PMID:11436868 |
|
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
|
|
G |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
increases response to substance |
EXP |
HLA-DRB1 gene polymorphism results in increased susceptibility to Auranofin |
CTD |
PMID:11436868 |
|
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
EXP ISO |
Auranofin results in increased expression of HMOX1 mRNA Auranofin results in increased expression of HMOX1 mRNA; Auranofin results in increased expression of HMOX1 protein |
CTD |
PMID:22008538 PMID:23942037 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
EXP |
Auranofin inhibits the reaction [IL1B protein affects the localization of RELA protein]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:10594346 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of IL6ST protein; [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of JAK2 protein; [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:20542334 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IL6ST |
interleukin 6 cytokine family signal transducer |
multiple interactions |
EXP |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of IL6ST protein |
CTD |
PMID:20542334 |
|
NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022
|
|
G |
IRAK1 |
interleukin 1 receptor associated kinase 1 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [lipopolysaccharide A results in increased degradation of IRAK1 protein] |
CTD |
PMID:17034761 |
|
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
|
|
G |
IRF3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [lipopolysaccharide A results in increased activity of IRF3 protein]; Auranofin inhibits the reaction [lipopolysaccharide A results in increased phosphorylation of IRF3 protein]; Auranofin inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein]; Auranofin inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
|
|
G |
ITGAM |
integrin subunit alpha M |
multiple interactions |
EXP |
[Auranofin co-treated with Tretinoin] results in increased expression of ITGAM protein |
CTD |
PMID:15159275 |
|
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
|
|
G |
JAK2 |
Janus kinase 2 |
multiple interactions |
EXP |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of JAK2 protein |
CTD |
PMID:20542334 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:36343453 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:36343453 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:36343453 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions decreases expression |
EXP |
[Auranofin co-treated with SN50 peptide] results in decreased expression of MCL1 protein Auranofin results in decreased expression of MCL1 protein |
CTD |
PMID:20542334 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
Auranofin promotes the reaction [arsenite results in increased expression of NFE2L2 protein] |
CTD |
PMID:36343453 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
Auranofin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] |
CTD |
PMID:10820281 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NFKBIB |
NFKB inhibitor beta |
multiple interactions |
ISO |
Auranofin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIB protein] |
CTD |
PMID:10820281 |
|
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
decreases activity increases cleavage |
EXP |
Auranofin results in decreased activity of PARP1 protein Auranofin results in increased cleavage of PARP1 protein |
CTD |
PMID:15159275 PMID:21370912 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PPIF |
peptidylprolyl isomerase F |
increases oxidation multiple interactions |
EXP ISO |
Auranofin results in increased oxidation of PPIF protein Auranofin inhibits the reaction [[NADP co-treated with TXNRD1 protein] results in increased activity of PPIF protein]; Cyclosporine promotes the reaction [Auranofin results in increased oxidation of PPIF protein] |
CTD |
PMID:26975474 |
|
NCBI chr10:79,347,469...79,355,334
Ensembl chr10:79,347,469...79,355,334
|
|
G |
PRDX3 |
peroxiredoxin 3 |
increases oxidation multiple interactions |
ISO EXP |
Auranofin results in increased oxidation of PRDX3 protein Cyclosporine promotes the reaction [Auranofin results in increased oxidation of PRDX3 protein] Auranofin promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of PRDX3 protein] |
CTD |
PMID:18789312 PMID:21355852 PMID:26975474 |
|
NCBI chr10:119,167,720...119,178,812
Ensembl chr10:119,167,720...119,178,812
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO EXP |
[lipopolysaccharide A co-treated with Auranofin] results in decreased expression of PTGS2 protein Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:10594346 PMID:17034761 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RB1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
EXP |
Auranofin results in decreased phosphorylation of RB1 protein |
CTD |
PMID:20542334 |
|
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
|
|
G |
RBMS3 |
RNA binding motif single stranded interacting protein 3 |
affects response to substance |
EXP |
RBMS3 protein affects the susceptibility to Auranofin |
CTD |
PMID:36414028 |
|
NCBI chr 3:29,281,071...30,010,395
Ensembl chr 3:28,574,791...30,010,391
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Auranofin inhibits the reaction [IL1B protein affects the localization of RELA protein]; Auranofin promotes the reaction [arsenite results in increased phosphorylation of RELA protein] |
CTD |
PMID:10594346 PMID:36343453 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
multiple interactions |
EXP |
Auranofin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
decreases expression multiple interactions |
EXP |
Auranofin results in decreased expression of STAT3 protein modified form [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:20542334 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
TBK1 |
TANK binding kinase 1 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr12:64,452,120...64,502,114
Ensembl chr12:64,452,090...64,502,114
|
|
G |
TGFA |
transforming growth factor alpha |
multiple interactions |
EXP |
Auranofin promotes the reaction [arsenite results in increased expression of and results in increased secretion of TGFA protein] |
CTD |
PMID:36343453 |
|
NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
|
|
G |
TICAM1 |
TIR domain containing adaptor molecule 1 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr19:4,815,932...4,831,712
Ensembl chr19:4,815,932...4,831,712
|
|
G |
TLR4 |
toll like receptor 4 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [lipopolysaccharide A promotes the reaction [TLR4 protein binds to TLR4 protein]] |
CTD |
PMID:17034761 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP ISO |
Auranofin inhibits the reaction [TNF protein results in increased activity of CHUK protein]; Auranofin promotes the reaction [TNF protein results in increased activity of CASP3 protein] Auranofin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] |
CTD |
PMID:10820281 PMID:18789312 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TXN |
thioredoxin |
increases oxidation multiple interactions |
EXP |
Auranofin results in increased oxidation of TXN protein Auranofin inhibits the reaction [arsenite results in increased expression of TXN protein] |
CTD |
PMID:26975474 PMID:36343453 |
|
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
|
|
G |
TXN2 |
thioredoxin 2 |
increases oxidation multiple interactions |
EXP ISO |
Auranofin results in increased oxidation of TXN2 protein Cyclosporine promotes the reaction [Auranofin results in increased oxidation of TXN2 protein] |
CTD |
PMID:26975474 |
|
NCBI chr22:36,467,046...36,481,640
Ensembl chr22:36,467,046...36,481,640
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
multiple interactions decreases activity increases oxidation increases expression |
EXP ISO |
Auranofin inhibits the reaction [arsenite results in increased expression of and results in increased activity of TXNRD1 protein]; Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]; Auranofin promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]; potassium tellurate(IV) promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]; Sodium Selenite promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein] Auranofin inhibits the reaction [[NADP co-treated with TXNRD1 protein] results in increased activity of PPIF protein]; Auranofin inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides] Auranofin results in decreased activity of TXNRD1 protein Auranofin results in increased expression of TXNRD1 mRNA |
CTD |
PMID:16510263 PMID:18405881 PMID:18789312 PMID:19486940 PMID:20457604 PMID:21172426 PMID:26975474 PMID:36343453 More...
|
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
TXNRD2 |
thioredoxin reductase 2 |
multiple interactions decreases activity |
EXP ISO |
Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD2 protein]; Auranofin promotes the reaction [Sodium Selenite results in decreased expression of TXNRD2 mRNA] Auranofin results in decreased activity of TXNRD2 protein |
CTD |
PMID:15458826 PMID:19486940 PMID:21172426 PMID:21355852 |
|
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
|
|
|
G |
TNF |
tumor necrosis factor |
decreases secretion |
ISO |
Topical GNP decreases secretion of Tnf protein in aqeous humor |
RGD |
PMID:23150627 |
RGD:7815044 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
AASS |
aminoadipate-semialdehyde synthase |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of AASS mRNA Gold analog results in decreased expression of AASS mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression |
EXP |
Gold analog results in increased expression of ABCB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCB4 mRNA Gold analog results in decreased expression of ABCB4 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCC1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
increases expression |
EXP |
Gold analog results in increased expression of ABCC2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABL1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675
|
|
G |
ACAA1 |
acetyl-CoA acyltransferase 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of ACAA1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242
|
|
G |
ACACA |
acetyl-CoA carboxylase alpha |
decreases expression |
EXP |
Gold analog results in decreased expression of ACACA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
|
|
G |
ACAD11 |
acyl-CoA dehydrogenase family member 11 |
decreases expression |
EXP |
Gold analog results in decreased expression of ACAD11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:132,558,141...132,659,809
Ensembl chr 3:132,558,138...132,660,082
|
|
G |
ACADM |
acyl-CoA dehydrogenase medium chain |
decreases expression |
EXP |
Gold analog results in decreased expression of ACADM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575
|
|
G |
ACADS |
acyl-CoA dehydrogenase short chain |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADS mRNA |
CTD |
PMID:28433809 |
|
NCBI chr12:120,725,826...120,740,008
Ensembl chr12:120,725,774...120,740,008
|
|
G |
ACADVL |
acyl-CoA dehydrogenase very long chain |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA |
CTD |
PMID:28433809 |
|
NCBI chr17:7,217,125...7,225,266
Ensembl chr17:7,217,125...7,225,266
|
|
G |
ACO1 |
aconitase 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:32,384,643...32,454,769
Ensembl chr 9:32,384,603...32,454,769
|
|
G |
ACO2 |
aconitase 2 |
decreases expression multiple interactions |
ISO EXP |
Gold analog results in decreased expression of ACO2 protein [Polyethyleneimine binds to Gold] which results in increased expression of ACO2 mRNA |
CTD |
PMID:24780912 PMID:28433809 |
|
NCBI chr22:41,469,117...41,528,974
Ensembl chr22:41,447,830...41,529,273
|
|
G |
ACOX1 |
acyl-CoA oxidase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ACOX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177
|
|
G |
ACOX2 |
acyl-CoA oxidase 2 |
decreases expression |
EXP |
Gold analog results in decreased expression of ACOX2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283
|
|
G |
ACP1 |
acid phosphatase 1 |
decreases expression |
EXP |
Gold results in decreased expression of ACP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:264,947...278,283
Ensembl chr 2:264,140...278,283
|
|
G |
ACVR1C |
activin A receptor type 1C |
decreases expression |
EXP |
Gold results in decreased expression of ACVR1C mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:157,526,767...157,628,864
Ensembl chr 2:157,526,767...157,628,864
|
|
G |
ADAM28 |
ADAM metallopeptidase domain 28 |
increases expression |
EXP |
Gold results in increased expression of ADAM28 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 8:24,294,069...24,359,014
Ensembl chr 8:24,294,069...24,359,014
|
|
G |
ADH5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
decreases expression |
EXP |
Gold results in decreased expression of ADH5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:99,070,978...99,088,788
Ensembl chr 4:99,070,978...99,088,801
|
|
G |
ADIPOR2 |
adiponectin receptor 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674
|
|
G |
ADRA1B |
adrenoceptor alpha 1B |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRA1B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:159,865,086...159,989,205
Ensembl chr 5:159,865,080...159,973,012
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRB2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
AHSG |
alpha 2-HS glycoprotein |
decreases expression |
EXP |
Gold analog results in decreased expression of AHSG mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
increases expression |
EXP |
Gold results in increased expression of AIFM1 protein |
CTD |
PMID:25462594 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
AIMP1 |
aminoacyl tRNA synthetase complex interacting multifunctional protein 1 |
decreases expression |
EXP |
Gold results in decreased expression of AIMP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:106,315,544...106,349,456
Ensembl chr 4:106,315,544...106,349,456
|
|
G |
AK3 |
adenylate kinase 3 |
decreases expression |
EXP |
Gold results in decreased expression of AK3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:4,709,556...4,742,043
Ensembl chr 9:4,709,556...4,742,043
|
|
G |
AKAP13 |
A-kinase anchoring protein 13 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of AKAP13 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr15:85,380,603...85,749,358
Ensembl chr15:85,380,571...85,749,358
|
|
G |
AKR1B10 |
aldo-keto reductase family 1 member B10 |
increases expression |
EXP |
Gold results in increased expression of AKR1B10 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
|
|
G |
AKR1C2 |
aldo-keto reductase family 1 member C2 |
increases expression |
EXP |
Gold results in increased expression of AKR1C2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
|
|
G |
AKR1C3 |
aldo-keto reductase family 1 member C3 |
increases expression |
EXP |
Gold results in increased expression of AKR1C3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:27470402 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
ALB |
albumin |
multiple interactions increases expression |
EXP |
ALB protein results in increased uptake of [Polyethylene Glycols binds to Gold]; ALB protein results in increased uptake of [Polyethyleneimine binds to Gold]; ALB protein results in increased uptake of [Thioctic Acid binds to Gold] Gold analog results in increased expression of ALB mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ANXA5 |
annexin A5 |
increases expression |
ISO |
Gold analog results in increased expression of ANXA5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
|
|
G |
APAF1 |
apoptotic peptidase activating factor 1 |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of APAF1 mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of APAF1 protein Gold analog results in decreased expression of APAF1 mRNA |
CTD |
PMID:27470402 PMID:28433809 PMID:36057382 |
|
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
|
|
G |
APEX1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of APEX1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
|
|
G |
APOA4 |
apolipoprotein A4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of APOA4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
|
|
G |
APRT |
adenine phosphoribosyltransferase |
decreases expression |
ISO |
Gold analog results in decreased expression of APRT protein |
CTD |
PMID:24780912 |
|
NCBI chr16:88,809,339...88,811,928
Ensembl chr16:88,809,339...88,811,937
|
|
G |
AQP4 |
aquaporin 4 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of AQP4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
|
|
G |
ARL1 |
ARF like GTPase 1 |
decreases expression |
EXP |
Gold results in decreased expression of ARL1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:101,393,116...101,407,820
Ensembl chr12:101,393,116...101,407,772
|
|
G |
ARL5B |
ARF like GTPase 5B |
decreases expression |
EXP |
Gold results in decreased expression of ARL5B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:18,659,431...18,681,639
Ensembl chr10:18,659,431...18,681,639
|
|
G |
ARSG |
arylsulfatase G |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ARSG mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:68,259,170...68,452,019
Ensembl chr17:68,259,182...68,422,731
|
|
G |
ASAH1 |
N-acylsphingosine amidohydrolase 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of ASAH1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
|
|
G |
ATF1 |
activating transcription factor 1 |
decreases expression |
EXP |
Gold results in decreased expression of ATF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:50,763,459...50,821,162
Ensembl chr12:50,763,710...50,821,162
|
|
G |
ATF4 |
activating transcription factor 4 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of ATF4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,686
|
|
G |
ATF6 |
activating transcription factor 6 |
increases cleavage |
EXP |
Gold analog results in increased cleavage of ATF6 protein |
CTD |
PMID:26551149 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
ATIC |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
decreases expression |
ISO |
Gold analog results in decreased expression of ATIC protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:215,312,059...215,368,592
Ensembl chr 2:215,311,956...215,349,773
|
|
G |
ATL2 |
atlastin GTPase 2 |
decreases expression |
EXP |
Gold results in decreased expression of ATL2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:38,293,954...38,378,584
Ensembl chr 2:38,293,954...38,377,285
|
|
G |
ATM |
ATM serine/threonine kinase |
decreases expression |
EXP |
Gold analog results in decreased expression of ATM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
|
|
G |
ATP2B1 |
ATPase plasma membrane Ca2+ transporting 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,366
|
|
G |
ATP5F1B |
ATP synthase F1 subunit beta |
multiple interactions |
ISO |
Gold analog results in increased expression of and results in decreased phosphorylation of ATP5F1B protein |
CTD |
PMID:24780912 |
|
NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984
|
|
G |
ATP6V1G2 |
ATPase H+ transporting V1 subunit G2 |
decreases expression |
EXP |
Gold analog results in decreased expression of ATP6V1G2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:31,544,444...31,546,742
Ensembl chr 6:31,544,444...31,548,427
|
|
G |
ATR |
ATR serine/threonine kinase |
decreases expression |
EXP |
Gold analog results in decreased expression of ATR mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
|
|
G |
BACE1 |
beta-secretase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BACE1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
|
|
G |
BAD |
BCL2 associated agonist of cell death |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in increased expression of BAD protein |
CTD |
PMID:27470402 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAIAP2 |
BAR/IMD domain containing adaptor protein 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of BAIAP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:81,035,151...81,117,434
Ensembl chr17:81,035,122...81,117,434
|
|
G |
BAK1 |
BCL2 antagonist/killer 1 |
increases expression |
EXP |
Gold results in increased expression of BAK1 mRNA |
CTD |
PMID:22178767 |
|
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein; [Gold analog co-treated with Platinum] results in increased expression of BAX mRNA; [Polyethyleneimine binds to Gold] which results in decreased expression of BAX mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of BAX protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of BAX protein Gold results in increased expression of BAX mRNA |
CTD |
PMID:21621595 PMID:22178767 PMID:25846798 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCAS2 |
BCAS2 pre-mRNA processing factor |
decreases expression |
EXP |
Gold results in decreased expression of BCAS2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:114,567,557...114,581,615
Ensembl chr 1:114,567,557...114,581,629
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP ISO |
[Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA; [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein |
CTD |
PMID:25846798 PMID:27470402 PMID:27836789 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BCL2L11 |
BCL2 like 11 |
decreases expression |
EXP |
Gold analog results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
|
|
G |
BIRC2 |
baculoviral IAP repeat containing 2 |
decreases expression |
EXP |
Gold results in decreased expression of BIRC2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
|
|
G |
BIRC3 |
baculoviral IAP repeat containing 3 |
decreases expression |
EXP |
Gold analog results in decreased expression of BIRC3 mRNA; Gold results in decreased expression of BIRC3 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
|
|
G |
BMAL1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BMAL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
|
|
G |
BMI1 |
BMI1 proto-oncogene, polycomb ring finger |
decreases expression |
EXP |
Gold results in decreased expression of BMI1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:22,321,099...22,331,706
Ensembl chr10:22,321,099...22,331,484
|
|
G |
BRCA1 |
BRCA1 DNA repair associated |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA1 mRNA Gold analog results in decreased expression of BRCA1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
|
|
G |
BRCA2 |
BRCA2 DNA repair associated |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA2 mRNA Gold analog results in decreased expression of BRCA2 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr13:32,315,077...32,400,268
Ensembl chr13:32,315,086...32,400,268
|
|
G |
C11orf54 |
chromosome 11 open reading frame 54 |
decreases expression |
EXP |
Gold results in decreased expression of C11ORF54 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:93,741,672...93,764,749
Ensembl chr11:93,741,591...93,764,749
|
|
G |
C1D |
C1D nuclear receptor corepressor |
decreases expression |
EXP |
Gold results in decreased expression of C1D mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:68,041,130...68,063,004
Ensembl chr 2:68,041,130...68,110,948
|
|
G |
C3 |
complement C3 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of C3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
C9 |
complement C9 |
decreases expression |
EXP |
Gold analog results in decreased expression of C9 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:39,284,140...39,364,495
Ensembl chr 5:39,284,140...39,371,324
|
|
G |
CA13 |
carbonic anhydrase 13 |
decreases expression |
EXP |
Gold results in decreased expression of CA13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:85,245,458...85,284,073
Ensembl chr 8:85,220,587...85,284,073
|
|
G |
CAPZA2 |
capping actin protein of muscle Z-line subunit alpha 2 |
decreases expression |
EXP |
Gold results in decreased expression of CAPZA2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:116,862,587...116,922,049
Ensembl chr 7:116,811,070...116,922,049
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of CASP1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity increases cleavage increases expression |
EXP ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP3 mRNA; [Polyethyleneimine binds to Gold] which results in increased expression of CASP3 mRNA; [Quercetin analog co-treated with Gold analog] results in increased cleavage of CASP3 protein; [Quercetin analog co-treated with Gold analog] results in increased expression of and results in increased activity of CASP3 protein; Dexamethasone promotes the reaction [Gold results in increased activity of CASP3 protein]; Etoposide promotes the reaction [Gold results in increased activity of CASP3 protein] Gold analog results in increased cleavage of CASP3 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP3 protein Gold results in increased expression of CASP3 mRNA |
CTD |
PMID:19760634 PMID:21621595 PMID:22178767 PMID:25846798 PMID:26551149 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP4 |
caspase 4 |
increases cleavage |
EXP |
Gold analog results in increased cleavage of CASP4 protein |
CTD |
PMID:26551149 |
|
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
|
|
G |
CASP7 |
caspase 7 |
increases cleavage |
EXP |
Gold analog results in increased cleavage of CASP7 protein |
CTD |
PMID:26551149 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
increases expression decreases expression |
EXP |
Gold results in increased expression of CASP8 mRNA Gold analog results in decreased expression of CASP8 mRNA |
CTD |
PMID:22178767 PMID:36057382 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases cleavage |
EXP ISO |
[Gold analog co-treated with Platinum] results in increased activity of CASP9 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA Gold analog results in increased cleavage of CASP9 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein |
CTD |
PMID:25846798 PMID:26551149 PMID:27836789 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein] |
CTD |
PMID:27836789 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CBX3 |
chromobox 3 |
decreases expression |
EXP |
Gold results in decreased expression of CBX3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:26,201,443...26,213,607
Ensembl chr 7:26,201,162...26,213,607
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein Gold results in increased secretion of CCL2 protein |
CTD |
PMID:22155353 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein Gold results in increased secretion of CCL5 protein |
CTD |
PMID:22155353 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL7 protein Gold results in increased secretion of CCL7 protein |
CTD |
PMID:22155353 |
|
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions |
EXP |
[Quercetin analog co-treated with Gold analog] results in decreased expression of CCND1 protein |
CTD |
PMID:27470402 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCT5 |
chaperonin containing TCP1 subunit 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of CCT5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 5:10,249,921...10,266,412
Ensembl chr 5:10,249,929...10,266,389
|
|
G |
CD19 |
CD19 molecule |
increases expression |
EXP |
Gold analog results in increased expression of CD19 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:28,931,971...28,939,342
Ensembl chr16:28,931,965...28,939,342
|
|
G |
CD36 |
CD36 molecule (CD36 blood group) |
decreases expression |
EXP |
Gold analog results in decreased expression of CD36 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
|
|
G |
CD40 |
CD40 molecule |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CD40 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD86 |
CD86 molecule |
decreases expression |
EXP |
Gold analog results in decreased expression of CD86 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CDA |
cytidine deaminase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,589,086...20,618,903
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
decreases expression increases expression |
EXP |
Gold results in decreased expression of CDK1 mRNA Gold results in increased expression of CDK1 mRNA |
CTD |
PMID:25523186 PMID:29705079 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CDK7 |
cyclin dependent kinase 7 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CDK7 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:69,234,795...69,277,430
Ensembl chr 5:69,234,795...69,277,430
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
EXP |
[Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein |
CTD |
PMID:17079469 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN2AIP |
CDKN2A interacting protein |
decreases expression |
EXP |
Gold results in decreased expression of CDKN2AIP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:183,444,636...183,449,064
Ensembl chr 4:183,444,635...183,449,064
|
|
G |
CGRRF1 |
cell growth regulator with ring finger domain 1 |
decreases expression |
EXP |
Gold results in decreased expression of CGRRF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:54,509,906...54,539,292
Ensembl chr14:54,509,812...54,539,292
|
|
G |
CHEK1 |
checkpoint kinase 1 |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CHEK1 mRNA Gold analog results in decreased expression of CHEK1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
|
|
G |
CHEK2 |
checkpoint kinase 2 |
decreases expression |
EXP |
Gold analog results in decreased expression of CHEK2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
|
|
G |
CHORDC1 |
cysteine and histidine rich domain containing 1 |
decreases expression |
EXP |
Gold results in decreased expression of CHORDC1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:90,200,429...90,223,049
Ensembl chr11:90,200,429...90,223,077
|
|
G |
CISD1 |
CDGSH iron sulfur domain 1 |
decreases expression |
EXP |
Gold results in decreased expression of CISD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:58,269,162...58,289,586
Ensembl chr10:58,269,162...58,289,586
|
|
G |
CLDN12 |
claudin 12 |
decreases expression |
EXP |
Gold results in decreased expression of CLDN12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:90,403,461...90,415,954
Ensembl chr 7:90,383,721...90,513,402
|
|
G |
CNBP |
CCHC-type zinc finger nucleic acid binding protein |
decreases expression |
EXP |
Gold results in decreased expression of CNBP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:129,167,827...129,183,896
Ensembl chr 3:129,167,827...129,183,922
|
|
G |
CNOT7 |
CCR4-NOT transcription complex subunit 7 |
decreases expression |
EXP |
Gold results in decreased expression of CNOT7 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:17,224,966...17,246,857
Ensembl chr 8:17,224,966...17,246,878
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
Gold analog results in increased expression of COL1A1 protein |
CTD |
PMID:24780912 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL1A2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL3A1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
COMMD8 |
COMM domain containing 8 |
decreases expression |
EXP |
Gold results in decreased expression of COMMD8 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:47,450,787...47,463,702
Ensembl chr 4:47,450,787...47,463,702
|
|
G |
COX11 |
cytochrome c oxidase copper chaperone COX11 |
decreases expression |
EXP |
Gold results in decreased expression of COX11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:54,951,902...54,968,785
Ensembl chr17:54,951,902...54,968,703
|
|
G |
COX17 |
cytochrome c oxidase copper chaperone COX17 |
decreases expression |
EXP |
Gold results in decreased expression of COX17 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:119,663,975...119,677,406
Ensembl chr 3:119,654,513...119,677,454
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
|
|
G |
CPT2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197
|
|
G |
CROT |
carnitine O-octanoyltransferase |
decreases expression |
EXP |
Gold analog results in decreased expression of CROT mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:87,345,664...87,399,794
Ensembl chr 7:87,345,664...87,399,794
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein Gold results in increased secretion of CSF2 protein |
CTD |
PMID:22155353 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CSF3 |
colony stimulating factor 3 |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of CSF3 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF3 protein |
CTD |
PMID:22155353 |
|
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
|
|
G |
CTCF |
CCCTC-binding factor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CTCF mRNA |
CTD |
PMID:19695318 |
|
NCBI chr16:67,562,526...67,639,185
Ensembl chr16:67,562,467...67,639,177
|
|
G |
CUX1 |
cut like homeobox 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CUX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:101,816,007...102,283,958
Ensembl chr 7:101,815,904...102,283,958
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of CXCL10 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein |
CTD |
PMID:22155353 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL2 mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL2 protein Gold results in increased secretion of CXCL2 protein |
CTD |
PMID:19695318 PMID:22155353 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CYCS |
cytochrome c, somatic |
multiple interactions |
EXP |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of CYCS protein |
CTD |
PMID:21621595 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases activity decreases expression multiple interactions |
ISO EXP |
Gold analog results in increased activity of CYP1A1 protein Gold analog results in decreased expression of CYP1A1 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:20193702 PMID:28433809 PMID:36057382 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP24A1 |
cytochrome P450 family 24 subfamily A member 1 |
increases expression |
EXP |
Gold results in increased expression of CYP24A1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr20:54,143,538...54,173,986
Ensembl chr20:54,153,446...54,173,986
|
|
G |
CYP2D6 |
cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene) |
multiple interactions decreases expression |
EXP |
[Polyethyleneimine binds to Gold] which results in decreased expression of CYP2D6 mRNA Gold analog results in decreased expression of CYP2D6 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
EXP |
Gold analog results in increased expression of CYP7A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
CYTH1 |
cytohesin 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CYTH1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:78,674,048...78,782,273
Ensembl chr17:78,674,048...78,782,297
|
|
G |
DAB2 |
DAB adaptor protein 2 |
increases expression |
EXP |
Gold results in increased expression of DAB2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300
|
|
G |
DCP2 |
decapping mRNA 2 |
decreases expression |
EXP |
Gold results in decreased expression of DCP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:112,976,798...113,022,195
Ensembl chr 5:112,976,702...113,022,195
|
|
G |
DDC |
dopa decarboxylase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DDC mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions |
EXP |
[Polyethyleneimine binds to Gold] which results in increased expression of DDIT3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of DDIT4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
| |